STUDYID|DOMAIN|USUBJID|DSSEQ|DSTERM|DSDECOD|DSCAT|DSSCAT|EPOCH|DSDTC|DSSTDTC|DSDY|DSSTDY
e|DS|35f5401f-575a-44dc-9141-8084716a5b70|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2020-11-19|2020-10-21|40|11
e|DS|8a863a88-67d8-4e50-bafa-c3146591f046|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2020-12-31|2020-12-30|12|11
e|DS|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2020-10-24|2020-08-06|92|13
e|DS|0558cb35-f542-4f9a-a7e7-18b1d71be69c|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2021-02-26|2021-01-14|78|35
e|DS|a9cf4d21-c2a8-4f32-b932-f05d2d317400|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2020-09-02|2020-08-15|71|53
e|DS|0389257f-50de-4a05-8f2a-69c068374337|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-10-05|2020-10-04|7|6
e|DS|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-01-23|2021-01-12|49|38
e|DS|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-01-19|2020-12-14|38|2
e|DS|ad402b62-0625-431b-9bd7-ffd6124610f3|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-09-29|2020-09-26|14|11
e|DS|d76b0f55-541c-491d-9162-4c133c9509f1|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-05-31|2020-05-21|17|7
e|DS|146059d8-5652-41cd-b484-c6e5d8ea540f|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2020-09-03|2020-08-31|18|15
e|DS|3d5f1964-b65c-4a0a-bb5b-1689308754d8|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-11-25|2020-11-15|31|21
e|DS|129dc836-068a-463e-b789-a0d05c60605d|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-08-22|2020-08-21|57|56
e|DS|9ef8a6d4-8326-4050-be85-e9f8983f55c1|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2020-12-26|2020-11-16|59|19
e|DS|b91c4469-b3be-467f-8512-b73cf561e168|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-07-04|2020-06-21|57|44
e|DS|3637e1e0-8c0c-45cc-b139-e812a589f940|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-30|2020-09-21|71|32
e|DS|23385974-5fcd-4c36-b9fa-2fbb3841f182|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-02-11|2021-01-04|86|48
e|DS|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2020-12-11|2020-12-01|15|5
e|DS|f1327e16-08c6-4ef0-852e-13c095a94c00|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-05-26|2020-05-21|10|5
e|DS|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2021-04-07|2021-03-23|92|77
e|DS|e8065021-c163-41c8-8a76-5f0c1c3a06c4|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2021-02-04|2021-01-03|68|36
e|DS|854a9218-995e-47f4-87ab-e58d20f56d19|1|[?]|DEATH|OTHER EVENT|STUDY TREATMENT|WASHOUT|2021-02-17|2020-12-15|96|32
e|DS|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-06-18|2020-06-15|7|4
e|DS|08944dcd-a62d-4932-bb15-a8f15cc73229|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2021-03-17|2021-02-14|94|63
e|DS|1d7df560-695a-41fe-9226-4cc206b05f48|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2021-01-26|2021-01-08|58|40
e|DS|12c802a8-862c-45a4-b12c-a6f920772534|1|[?]|DEATH|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-08-05|2020-08-04|59|58
e|DS|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-12-17|2020-12-02|34|19
e|DS|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-09-19|2020-08-19|44|13
e|DS|96114171-59a0-4543-b3ec-c7796ae8ee92|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-01-03|2020-12-07|50|23
e|DS|0070d42d-c864-4a83-a3c9-4c8ca7de51de|1|[?]|DEATH|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2020-10-19|2020-08-10|75|5
e|DS|a2ec3389-6f5f-44a3-a6dd-f6177a805791|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2021-01-13|2020-12-24|98|78
e|DS|cc562042-9641-460d-862e-d6923dd4207d|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-07-16|2020-06-07|60|21
e|DS|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2020-10-06|2020-09-23|78|65
e|DS|d90f2824-692e-403f-b1ca-5b6462c93a75|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-10-12|2020-09-07|99|64
e|DS|ee0e55e1-6107-4a3c-85b4-cb48300153e8|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2020-07-25|2020-07-08|71|54
e|DS|6aa37bb3-85aa-427f-9e56-a776257f1548|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-11-24|2020-11-09|20|5
e|DS|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-08-12|2020-07-13|96|66
e|DS|940d4614-b41a-44d3-b878-6e19ee22f24b|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-08-24|2020-08-02|59|37
e|DS|e2edd4f0-926b-4514-bf3f-7449f248343f|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2021-01-24|2020-11-29|94|38
e|DS|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2020-08-06|2020-06-20|49|2
e|DS|493a53ef-01ab-470c-9bbe-7c2aa48b946b|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-08-10|2020-07-08|38|5
e|DS|ba33de14-b676-4389-a863-a7fa3edb8543|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2021-01-19|2020-11-01|87|8
e|DS|24801f05-79be-433d-8124-85580bc14c4f|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-10-12|2020-09-02|43|3
e|DS|02df80f9-2337-4abd-9452-41cd83dec8ba|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-08-06|2020-08-05|12|11
e|DS|d9eea93b-f9f9-466c-aa8a-a250baff18ef|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2020-09-04|2020-08-07|42|14
e|DS|35a59f6a-2712-4d1b-a954-f1418d4b9168|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-11-25|2020-11-05|30|10
e|DS|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-01-31|2020-11-09|92|9
e|DS|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2020-06-27|2020-05-22|55|19
e|DS|d041952e-4aa6-4b37-9cec-127adce2eabb|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2020-12-13|2020-10-25|75|26
e|DS|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-08-14|2020-08-06|76|68
e|DS|9fc393da-4665-4be5-a869-856c45ddcf13|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-08-20|2020-06-24|73|16
e|DS|cddc1541-4de9-45e7-bb61-15a2d5baca6f|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-03-23|2021-03-21|73|71
e|DS|303c6dbe-59f9-4016-baa1-8506c0c1ee09|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-01-18|2021-01-01|33|16
e|DS|fee3c810-3d76-4db4-9272-6b4e8fd14088|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2020-12-15|2020-12-08|10|3
e|DS|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-08-04|2020-07-06|37|8
e|DS|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-08-25|2020-08-05|34|14
e|DS|47fad45a-9a4c-47ee-a863-089d979523b5|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-07|2020-10-05|10|8
e|DS|317b8b6d-9638-44a3-816f-7f3fca1e01a3|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2020-06-06|2020-05-15|24|2
e|DS|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-09-17|2020-07-24|79|24
e|DS|e7cee930-54f6-482e-b782-01aed0f0db06|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2021-01-15|2021-01-10|18|13
e|DS|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|1|[?]|DEATH|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-03-18|2021-01-24|66|13
e|DS|f754ae7d-0776-41c0-988c-8cf2879d85da|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-12-01|2020-10-23|85|46
e|DS|8a8d8c31-ae36-4a64-90da-ba5eb473e420|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2020-09-10|2020-09-08|87|85
e|DS|482e40c9-2908-4269-b93c-61c311e9fde3|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2020-07-29|2020-07-21|23|15
e|DS|f7cfb281-0556-4316-9373-65edf63c4b23|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2020-07-11|2020-07-03|22|14
e|DS|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2021-02-23|2021-01-27|54|27
e|DS|9ed8a578-a82a-423a-81ca-ee87f98d62f7|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2020-10-18|2020-09-27|56|35
e|DS|2214af46-1072-4328-bf3d-f4fe9cd97d9b|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-28|2020-10-19|20|11
e|DS|7e56eb43-62a6-45ac-9476-1d0655595a04|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-03-24|2021-03-11|69|56
e|DS|73a8e85a-0b5f-496b-b164-afc4d1f02de2|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2020-07-22|2020-07-16|33|27
e|DS|84f74359-c79b-4f1c-8119-a4993b071973|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-06-17|2020-05-18|46|16
e|DS|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2021-01-08|2020-11-21|73|25
e|DS|cd0c969e-61c6-4c65-ac19-4ee247f5009a|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-11-08|2020-09-18|70|19
e|DS|1fff484d-0a68-42cd-8eff-bc4fe4da945c|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2021-04-23|2021-03-17|95|58
e|DS|e2c20e9a-0ac5-4907-96de-472bee70bd79|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2021-02-22|2020-12-23|90|29
e|DS|6064ca8c-b723-4d05-914a-bb547d86fcc5|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-06-19|2020-06-02|27|10
e|DS|8effbbff-acda-4718-89f1-e30a418f6bae|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2021-01-25|2020-12-25|90|59
e|DS|859b16a5-f6a2-40cc-8e01-18c112b1969e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-10-24|2020-09-24|77|47
e|DS|36b457ef-4cf6-4043-a836-49368ebf3f1c|1|[?]|DEATH|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-27|2020-08-08|82|2
e|DS|31f33e38-bba6-4c8a-b563-14afaabae5d7|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-06-25|2020-06-24|4|3
e|DS|6794dffe-333b-425b-8883-26f6e5ba0797|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-07-16|2020-07-01|17|2
e|DS|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-08-21|2020-08-16|85|80
e|DS|45897452-8f5a-458d-9a43-13237460ba48|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-12-28|2020-12-14|57|43
e|DS|16eb981f-2118-4658-a83f-93d925c410c9|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2021-03-01|2021-02-16|85|72
e|DS|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-02-12|2021-01-29|42|28
e|DS|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-02-06|2021-01-30|18|11
e|DS|874f491c-5d55-4738-86b7-b1200b16d106|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-02-25|2021-02-17|58|50
e|DS|281ccdef-794c-49ad-9616-6f6f68dd4543|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2020-08-21|2020-05-30|88|5
e|DS|b1179e10-e8fe-472c-a511-d6d460571857|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-10-15|2020-07-29|84|6
e|DS|6362cf42-f286-4151-bdf7-38fcc5639eed|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2020-11-25|2020-10-17|89|50
e|DS|8e28e3ab-0060-43f7-b033-c16bd77c0e29|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-12-12|2020-12-09|22|19
e|DS|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2020-08-11|2020-07-06|55|19
e|DS|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2020-06-29|2020-06-27|17|15
e|DS|43880587-c397-402d-886b-9b666e3fe455|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2020-09-25|2020-08-15|76|35
e|DS|807f83d2-9364-4ee4-855d-304f3e252555|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-06-04|2020-05-21|31|17
e|DS|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2021-01-01|2020-12-29|33|30
e|DS|81c33633-6ade-45fe-a78e-0e853d8aa9c2|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-11-02|2020-09-30|89|56
e|DS|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-09-28|2020-08-23|68|32
e|DS|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-10|2020-09-05|49|14
e|DS|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2021-03-27|2021-02-09|69|23
e|DS|21740641-69bb-49a9-a86d-2444914f6d12|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-07-01|2020-06-16|55|40
e|DS|c3984f41-30a0-49a4-a8bd-f36fad4621a8|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-06-21|2020-06-17|13|9
e|DS|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2021-01-15|2021-01-13|4|2
e|DS|0f85b859-187d-4c6b-8873-33c0f18d3e3c|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2020-09-11|2020-08-25|59|42
e|DS|5e383a9d-dc97-4352-8add-d55a1a566b9f|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-10-26|2020-10-12|39|25
e|DS|3eda746b-fb97-4950-a528-1d4ae5d3653a|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-06-05|2020-06-05|2|2
e|DS|a3b72841-3401-4dcc-9d06-75438b408d0b|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2020-11-28|2020-11-10|33|15
e|DS|4393406e-bda5-42e4-a752-a8121004b7ef|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-01-13|2020-11-12|87|25
e|DS|d70f5903-3d94-422b-8f69-212f015b54c9|1|[?]|DEATH|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-08-11|2020-06-18|94|40
e|DS|ef772266-faf1-4904-8ac3-19cbc3ea7d36|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-03-08|2021-02-17|71|52
e|DS|c0f9c36c-1ae5-4f80-b936-0afe3f661746|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-08-03|2020-07-12|30|8
e|DS|f17b5630-e782-4135-8a50-4a9bb2fe63b1|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-02-09|2021-01-08|82|50
e|DS|8bdb40c9-1e44-45ae-bf08-81ea635fd762|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-03-12|2021-01-25|79|33
e|DS|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2021-03-27|2021-02-16|80|41
e|DS|296f8314-5a07-47b5-8796-31afe709b379|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-09-25|2020-08-31|89|64
e|DS|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-12-16|2020-12-14|13|11
e|DS|b06043ae-8251-4df8-ab6d-0ceb269c1a42|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2021-03-02|2021-01-30|46|15
e|DS|d4fb5b9e-e244-4818-be3d-dbb57faacd43|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2021-01-05|2020-12-24|69|57
e|DS|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2020-07-05|2020-07-05|2|2
e|DS|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2021-02-06|2021-02-02|33|29
e|DS|b1215705-4c22-43bd-aa65-58bd8745f081|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-09-09|2020-08-28|66|54
e|DS|b99c6528-af4e-42f5-8d2d-18943b57d55a|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-11-25|2020-11-09|41|25
e|DS|6848e438-51ca-4a7d-8f81-26c375969a64|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2021-01-07|2020-11-12|66|10
e|DS|a6e11c33-7905-42d2-bda9-671d756d4c51|1|[?]|DEATH|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2020-10-20|2020-09-02|85|37
e|DS|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-12-10|2020-11-11|38|9
e|DS|8ef37b54-b463-43a4-879f-3ad653c4fef4|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-16|2020-10-05|45|34
e|DS|cf10035c-4d44-4512-810b-c267d1c8821b|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-05-21|2020-05-20|4|3
e|DS|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-10-14|2020-08-11|84|20
e|DS|a1e0035a-3328-4966-8664-82e53a44eb59|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-10-03|2020-09-06|64|37
e|DS|771377fd-724f-4056-b2ea-84e1adab1f47|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-11-16|2020-11-11|18|13
e|DS|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-08-15|2020-08-15|2|2
e|DS|3aea0861-8f67-4717-93ce-c1e322f151d9|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-08-10|2020-08-09|6|5
e|DS|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-10-30|2020-09-27|35|2
e|DS|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-03-07|2021-01-21|77|32
e|DS|39f51bd8-5edc-4434-92d4-7d8b683a6c32|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-11-21|2020-10-18|73|39
e|DS|80565a22-8cec-46a2-abd7-91daf0767035|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-02-08|2021-01-27|21|9
e|DS|585a254e-c36b-44cf-b8a9-335fb98e0fd2|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2020-11-19|2020-10-26|41|17
e|DS|9ee3632d-4e99-4a46-b0b9-237467d97ca0|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2020-09-22|2020-09-09|23|10
e|DS|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-07-22|2020-06-17|46|11
e|DS|34b2090b-13ac-4fb2-8d87-eca2839a62f2|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-07-18|2020-06-26|51|29
e|DS|bfc19b4b-51bb-4056-9195-8bd2db53a497|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-25|2020-08-14|71|29
e|DS|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-11-14|2020-11-05|64|55
e|DS|64a70103-14bf-42f4-808b-fbdecec8bd4f|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2020-09-30|2020-09-04|31|5
e|DS|00f3949b-b14a-47c5-942c-2ab71e03e40f|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-04-07|2021-01-11|88|2
e|DS|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-01-03|2020-12-19|17|2
e|DS|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2020-07-21|2020-07-12|12|3
e|DS|44ca1fe6-76d2-4a94-9854-1ddbde638803|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-07-17|2020-07-11|8|2
e|DS|edc935ed-3b94-43fa-9b7f-facf6eb6780e|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-01-05|2020-12-31|42|37
e|DS|f997ad2a-e9b1-4341-96d5-caef4bcb7196|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-08-10|2020-06-08|73|10
e|DS|5a56874f-10e4-4cd0-842f-19552a04d1bd|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-07-31|2020-07-25|51|45
e|DS|f1d4ebe5-fc72-447b-8872-67e971ff471b|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2021-02-02|2020-11-19|96|21
e|DS|2a141b73-e336-4701-9067-8d51d532596b|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2020-07-07|2020-06-21|35|19
e|DS|4adf9a2c-3c43-4289-8156-1a109791580c|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2020-12-22|2020-12-05|40|23
e|DS|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2020-06-16|2020-05-26|34|13
e|DS|1b2eda86-2d2c-4fdc-a88e-409ea5180603|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2020-07-31|2020-05-30|83|21
e|DS|fc02184a-dfba-4964-be3a-cfa5f5d7200e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-05-21|2020-05-19|5|3
e|DS|37c59cfa-b952-4d16-a675-5e3b3a2e0288|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-06-07|2020-05-25|19|6
e|DS|11130b2c-e9fd-4a50-87ee-5dfa19199eba|1|[?]|DEATH|OTHER EVENT|STUDY TREATMENT|SCREENING|2021-01-30|2020-12-20|68|27
e|DS|08e4310f-f868-4858-a321-f33a21a771e8|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-06-03|2020-05-20|29|15
e|DS|29edf133-8b5b-46d5-bf7a-f75af4658417|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-09-20|2020-09-04|39|23
e|DS|49756233-e18f-4187-8d48-3b6b4fa7e5c2|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2020-08-09|2020-08-02|10|3
e|DS|7a046104-7215-4708-9d85-66683ceb8fe8|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2021-01-06|2020-12-24|92|79
e|DS|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-02-12|2021-01-27|27|11
e|DS|bcbe7d50-2ebe-483a-9d71-dce4094f864e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-06-09|2020-05-27|25|12
e|DS|2550ba24-7bcf-41e2-9eae-536e13d4b345|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-03-07|2021-02-25|56|46
e|DS|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2020-08-12|2020-08-11|8|7
e|DS|6ec23671-252e-4dc9-b919-88254fce68a5|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2020-07-21|2020-07-20|3|2
e|DS|db59e5e1-ccda-480b-8955-da5157e16c4a|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2020-07-15|2020-07-09|72|66
e|DS|1dce856e-b7cb-4899-b27f-87ab8d918df4|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-11-14|2020-09-27|73|25
e|DS|7449180b-e226-4e97-a059-8760f6523f77|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-17|2020-07-15|85|21
e|DS|f077c497-b0f0-4a20-b448-608b0cc6ab36|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-08-05|2020-07-21|68|53
e|DS|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-09-09|2020-08-14|99|73
e|DS|3f7c46ac-fe30-4ef3-a581-99c064a85efa|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-01-06|2021-01-03|5|2
e|DS|8d944400-df75-4ec7-8fb4-239eb0f6de9d|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2020-10-09|2020-09-26|27|14
e|DS|7b201f93-bd8c-4507-a7b7-27a02e364647|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2021-02-25|2021-01-17|74|35
e|DS|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2020-10-23|2020-09-13|89|49
e|DS|3611b798-9b3d-4173-b23e-3017939847e0|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-10-21|2020-09-07|89|45
e|DS|f651799b-9723-4c2c-88d1-de2f347e9a69|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-08-31|2020-06-18|78|4
e|DS|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2020-11-09|2020-10-28|31|19
e|DS|29b16c31-df0e-493c-a777-46113b904879|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-08-31|2020-07-21|95|54
e|DS|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-08-01|2020-07-27|11|6
e|DS|118914c8-9f6a-47c8-b427-296a99547756|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2021-01-05|2020-11-25|82|41
e|DS|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-01-15|2020-12-24|47|25
e|DS|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-02-27|2021-02-24|60|57
e|DS|7a5ae465-03b9-4006-a29e-94822ed857aa|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-08-21|2020-07-19|60|27
e|DS|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-10-17|2020-09-27|35|15
e|DS|2e4cd860-734a-40b0-bde5-ca08297415a9|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2021-02-15|2021-01-10|92|56
e|DS|3f1854fb-d14e-4699-888b-d5042fa9327c|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-09-23|2020-08-08|60|14
e|DS|f6e37eba-e224-47f3-baa0-59dfdfb47b70|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2021-01-28|2020-12-06|59|6
e|DS|8298b45d-16ff-42ef-8404-0f3ce628f9e5|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2020-09-26|2020-08-20|67|30
e|DS|ee5c6623-5cb4-4f18-99b0-6373328abc1d|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2020-09-07|2020-08-02|98|62
e|DS|f8d6576b-b300-4c5f-8f5a-6bb35250d576|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2020-09-15|2020-09-04|92|81
e|DS|8635a6b3-d16e-432c-90bf-53f1494dbe5e|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-11-02|2020-10-28|17|12
e|DS|2cda4297-410a-49e4-949c-deb3dc4c6656|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2020-09-14|2020-07-27|96|47
e|DS|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2021-04-03|2021-03-27|74|67
e|DS|9e82141b-e2b9-42c7-b813-b79bda2bd216|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-06-09|2020-05-23|19|2
e|DS|4b432c61-c620-4c5e-8aad-411facc0f4db|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-10-21|2020-09-20|47|16
e|DS|1a1e6863-26da-4b5d-b82a-5703e3e9056e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-03-08|2020-12-26|82|10
e|DS|8c8053d1-adae-4d45-870e-cf4ad2475c74|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-07-22|2020-06-09|82|39
e|DS|c3b911a8-116e-4940-80a2-7128db004f4a|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2021-02-06|2020-12-06|89|27
e|DS|401d66ba-bc00-4495-ba5d-796068dd1fd6|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-07-09|2020-06-04|38|3
e|DS|f8113725-4deb-48a1-876a-ba168a6d2cee|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2021-01-21|2021-01-15|9|3
e|DS|f056c174-b6da-4df6-bf95-2e31911939fb|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-12-14|2020-12-08|8|2
e|DS|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-25|2020-09-24|19|18
e|DS|57b7f30f-5f2a-425d-8bf2-fd5915cac481|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2021-03-07|2021-03-04|58|55
e|DS|02d9a74a-abc8-4b47-a4d4-a196d339f621|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-10-05|2020-09-07|31|3
e|DS|81480f83-206f-40c0-a5a4-f75b31cda363|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-12-02|2020-11-21|20|9
e|DS|2b183b69-3ed8-4356-b9e2-0988128de3f2|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-12-09|2020-10-22|64|16
e|DS|6ed8a749-81c0-4998-817d-efc86cfaa091|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-08-29|2020-06-30|95|35
e|DS|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-02-28|2021-01-23|51|15
e|DS|e6162980-e240-4924-a13a-dde28b2345cd|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-09-13|2020-09-03|43|33
e|DS|3dc9c666-8be3-4cfa-88d4-b18647e08d00|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-07-18|2020-06-18|45|15
e|DS|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2021-03-18|2021-01-27|64|14
e|DS|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-02-06|2020-12-17|89|38
e|DS|2738b933-c71d-4239-a093-6b4aa7cc41df|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-06-18|2020-05-20|31|2
e|DS|68b9ff4e-9694-4545-a752-4d3ac0e89fda|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2021-02-15|2021-01-24|48|26
e|DS|0f0ec179-5100-4a3d-9f93-54140aca7d30|1|[?]|DEATH|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-06|2020-09-02|22|18
e|DS|6affe43d-e455-40af-8478-dc38019e89e1|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-07-16|2020-06-30|39|23
e|DS|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-08-17|2020-07-03|81|36
e|DS|e0258c95-7bcc-4b54-895c-f290a1364b5c|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-03-03|2021-01-06|76|20
e|DS|7218f9ae-0119-4633-a8d3-7d98b2ae1671|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-03-07|2021-01-05|63|2
e|DS|f8c938ff-21c8-4d0b-9335-08d2865543ab|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-07-21|2020-05-23|81|22
e|DS|7176f852-7392-4636-800f-3aad48e93065|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-02-01|2021-01-15|26|9
e|DS|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-12-08|2020-11-16|71|49
e|DS|69e41d6b-57f7-48b0-be7a-29fca953f8d9|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-01-17|2020-12-15|91|58
e|DS|a38eb4fc-2422-4d4a-a435-58ae9bf42589|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2021-01-17|2020-11-28|65|15
e|DS|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|1|[?]|DEATH|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2020-11-14|2020-10-24|59|38
e|DS|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-01-09|2021-01-02|18|11
e|DS|dd518f55-0280-445d-a29f-10f09b21fd53|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2020-06-30|2020-05-17|53|9
e|DS|49a972da-dfad-438e-b5bc-26ee6b955a59|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-08-10|2020-06-18|57|4
e|DS|502a42a7-2ed6-46b9-9b10-728f849334b6|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2021-01-26|2021-01-15|76|65
e|DS|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2020-12-25|2020-12-23|70|68
e|DS|40c048ea-d637-426b-8afe-2da3a6961528|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-10|2020-09-19|99|78
e|DS|4d03b209-bd53-47f5-8251-f9fb2074bc38|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2021-03-08|2021-02-26|75|65
e|DS|35f01eda-1acb-4700-8285-c8cd4b69b524|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2020-12-26|2020-11-19|97|60
e|DS|9df97277-7d07-4020-bae0-dfa982f21c8d|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2020-12-23|2020-12-22|61|60
e|DS|d1b522d5-557a-4361-a9da-292aa601fbc3|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2021-01-03|2020-12-01|96|63
e|DS|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2020-09-02|2020-08-17|47|31
e|DS|da2d0844-3608-4927-9103-cb7c52dd2c96|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2021-03-19|2021-01-27|62|11
e|DS|30b6f8a7-4512-462d-a162-45c3dad853e5|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-12-12|2020-12-07|20|15
e|DS|1a3808b9-6004-4133-8f59-49905d04655e|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2020-12-08|2020-12-04|41|37
e|DS|5c91894d-c756-4ade-9fc4-2a64d4acc53f|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2021-01-30|2021-01-16|21|7
e|DS|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-08-30|2020-08-17|56|43
e|DS|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2020-10-31|2020-10-28|56|53
e|DS|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-07-20|2020-06-17|50|17
e|DS|37610314-f803-4ffa-a584-ebfe09267a0d|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2020-08-31|2020-08-07|72|48
e|DS|760ec5ce-3ae7-4268-9f76-b83085ad3754|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-10-22|2020-10-02|38|18
e|DS|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-06-19|2020-06-17|14|12
e|DS|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2021-02-14|2021-02-06|31|23
e|DS|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-02-01|2020-11-13|90|10
e|DS|d7b41e15-6725-4433-8a35-72629e342b47|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-11-14|2020-10-22|71|48
e|DS|aeddc1ed-545c-405e-b1f7-08131961f5ff|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-01-10|2020-10-14|97|9
e|DS|3effe272-6a68-4163-a4f3-bd269af6061c|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2021-04-07|2021-01-14|92|9
e|DS|8153c765-a92a-4b0f-9ef3-6ca925337f54|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-11-04|2020-10-20|46|31
e|DS|8d27cdcf-768e-4630-95b5-da554f6f3b56|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-12-17|2020-12-06|58|47
e|DS|5c2791ff-aaf6-413f-9827-6e97e2273388|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-09-17|2020-09-13|21|17
e|DS|b336d8c2-7bca-404e-aea3-5148d559ea99|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-10-04|2020-09-20|25|11
e|DS|702b2f8f-63b9-44c1-a46d-1a41bc837c32|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-08-04|2020-06-15|58|8
e|DS|1261eee1-f073-4419-b0b7-28abd0ec1513|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-26|2020-09-24|5|3
e|DS|46eefdf3-c314-4e61-963c-ce7f48c636e5|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2021-03-17|2021-01-31|88|43
e|DS|f632159b-8c91-4f0d-81cb-e5b9195588c9|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2021-02-27|2021-02-01|56|30
e|DS|898a9d2f-338b-41bf-8ac0-c4a025481349|1|[?]|DEATH|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2020-07-24|2020-06-27|71|44
e|DS|db3824aa-375d-4e40-a14b-af0e4460914e|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-07-11|2020-06-19|62|40
e|DS|0ea6be64-32f8-4e10-b993-687ea200e4e9|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-02-17|2021-02-03|30|16
e|DS|18504c4e-41c8-4c1a-a479-d179ccd318e3|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-07-03|2020-06-17|21|5
e|DS|7f211d8a-7478-4082-8d95-4ace9ceee919|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-10-14|2020-08-29|66|20
e|DS|0739e140-bcac-4df9-9629-bd0748d1fdd6|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2020-12-27|2020-10-13|89|14
e|DS|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-01-27|2021-01-09|47|29
e|DS|f24b931a-2cdd-4432-a1dd-69c7286f4690|1|[?]|DEATH|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-08-01|2020-06-25|88|51
e|DS|d394120d-7630-4fcf-a336-482599d88296|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2021-04-13|2021-02-11|91|30
e|DS|bcda1d95-58ed-4991-9395-0b98efc1d9a1|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2020-11-24|2020-10-14|44|3
e|DS|6999bd5c-0790-42b8-a4ff-e538776b0fb0|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-10-08|2020-09-20|64|46
e|DS|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-02-17|2021-02-03|68|54
e|DS|59b0fee3-2294-448e-9837-38bd6b5c794b|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-01-03|2020-12-29|12|7
e|DS|d9bdb1e3-4630-423f-be01-4873bce30422|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2021-01-11|2020-12-18|30|6
e|DS|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-06-17|2020-06-17|2|2
e|DS|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|1|[?]|DEATH|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-10-15|2020-07-31|82|6
e|DS|933c3a61-59a0-4cfb-ae17-45bc48229323|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-11-27|2020-10-08|89|39
e|DS|58d871e3-ef99-48da-ab12-fdfdc2e01da6|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-11-22|2020-11-05|37|20
e|DS|ac66129e-3244-4cd8-a235-43b4bfb7dace|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-12-20|2020-11-09|62|21
e|DS|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-11-09|2020-09-15|78|23
e|DS|3d59a754-10bb-4847-93ea-433b43265a2f|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2020-11-10|2020-11-05|27|22
e|DS|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2021-01-21|2021-01-12|11|2
e|DS|89209495-c485-4eb7-b858-8dc5490d2b64|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-11-20|2020-09-27|84|30
e|DS|d80522bb-f146-4270-a6e1-326fde50d9ca|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-03-27|2021-02-12|96|53
e|DS|3982a462-95f6-4e71-93e5-9df777770067|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2020-12-31|2020-12-17|16|2
e|DS|f3a3a6ca-2344-4cee-a6a5-59beee9304df|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-12-28|2020-11-18|59|19
e|DS|175cfd82-a6fe-463b-81e5-07ae9e1253db|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-06-09|2020-06-08|24|23
e|DS|e19b469c-40d5-4506-8233-a86bebde880d|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2021-03-16|2021-01-19|63|7
e|DS|f280a4a5-9826-4d77-adf1-992284cb3314|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-12-30|2020-12-16|21|7
e|DS|82840929-7800-4254-b60a-8af4786664f6|1|[?]|DEATH|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-08-10|2020-06-03|77|9
e|DS|dae25bdb-38fd-4852-9a9a-7627368e9497|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-09-17|2020-09-02|25|10
e|DS|9e009737-cd77-4b96-a4af-e9731ef7e9d0|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-12-06|2020-09-29|72|4
e|DS|e7468d01-71b3-47c4-9715-62fe143364cb|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-11-10|2020-11-03|36|29
e|DS|6a021859-1b18-4eb5-9548-0e32c0c1edf7|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-06-05|2020-05-15|28|7
e|DS|eb409ec5-4c02-41c8-a11f-03d990818c2a|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-01-06|2021-01-03|38|35
e|DS|2178f542-809d-4306-84e4-26d3b3b370b0|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-11-05|2020-11-02|9|6
e|DS|da7423fb-461e-43a6-bcb9-aa87051bda0a|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-10-26|2020-10-22|32|28
e|DS|40e4c69f-6115-4f0e-8555-45b12b222801|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2021-02-20|2021-02-14|31|25
e|DS|1307d7f6-acb6-4096-a907-08345548a82b|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2020-07-13|2020-06-17|56|30
e|DS|bac23835-1120-43b2-9d99-694bef97f44b|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2020-08-03|2020-05-30|84|19
e|DS|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-10-31|2020-10-25|47|41
e|DS|14cd64f5-f3c8-47a4-b40e-9c5090890870|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-10|2020-09-25|26|11
e|DS|ca4a06be-5e6a-4220-9854-e5fe02b384af|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-10-25|2020-10-15|32|22
e|DS|55504c69-a659-402b-a0cb-95ab4e08c086|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2021-02-12|2021-01-13|39|9
e|DS|bffa468a-a27b-4e87-a60d-b5787a03c6f6|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-11-25|2020-11-24|5|4
e|DS|2e25aa76-914f-41e3-82ce-7c56ba2f6271|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-01-26|2020-12-20|56|19
e|DS|12c24fff-080b-4889-a455-ff55d5c0536c|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2021-04-14|2021-04-04|87|77
e|DS|aecfe062-4e0d-4c91-8b67-1f304c5765ae|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2021-03-06|2021-01-20|54|9
e|DS|05a142dc-a779-44cb-ab2e-f961676a3940|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2021-01-07|2021-01-05|60|58
e|DS|498524c5-08c4-41a4-af81-876ab2452f64|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2021-01-12|2020-12-17|44|18
e|DS|93490930-01cd-470e-81a3-bcd7a140ccc1|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-11-24|2020-11-19|17|12
e|DS|fd588c97-c57f-432f-81a0-a116a017c5dd|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-06-16|2020-06-05|23|12
e|DS|18028efc-33b9-4741-a47a-8fdac0a90e6e|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-01-05|2021-01-03|24|22
e|DS|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-07-13|2020-06-22|49|28
e|DS|08fccce4-64bf-431e-81b0-a96566e77df6|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2021-03-08|2021-01-19|57|9
e|DS|0354fab5-5636-4504-8345-af060ad4c90c|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-04-10|2021-02-19|87|37
e|DS|f4f1a53a-d621-4f75-b44e-96b959aed03d|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2021-01-21|2021-01-06|22|7
e|DS|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-10-25|2020-10-09|34|18
e|DS|679423a4-92cf-4a93-8277-282f9b43f2ed|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-10-03|2020-09-20|71|58
e|DS|fb686cda-337b-46aa-b67b-790414201d9a|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2020-07-15|2020-07-09|60|54
e|DS|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-10-17|2020-09-30|22|5
e|DS|92d7a180-9353-41f8-93e2-ebcee32a1c63|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2020-12-17|2020-12-07|21|11
e|DS|5da18fbc-1274-4cb3-bb6b-b57872b9815b|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2020-11-03|2020-10-19|27|12
e|DS|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-02-18|2020-12-02|99|21
e|DS|4a195822-d646-4b22-a3b9-f6642442474d|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-08-03|2020-07-23|19|8
e|DS|515808c1-fda7-43bb-91dc-28e2d4e308cd|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-10-25|2020-09-23|58|26
e|DS|18461665-388d-403b-90e4-2b42fcb4a01a|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2020-11-03|2020-11-02|41|40
e|DS|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-11-05|2020-08-28|93|24
e|DS|e3ce1661-1b72-4835-88d1-5a6d3655b674|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-10-07|2020-08-12|66|10
e|DS|240844e9-3dda-438e-81b2-8f6aa4e0427e|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-02-06|2020-12-03|69|4
e|DS|fccf5c5d-deb6-4f13-a485-afcda3556578|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2020-09-10|2020-08-27|47|33
e|DS|94620ed0-1ae8-4fa5-a629-9210860b0be9|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-16|2020-08-22|53|28
e|DS|9c3b6912-19be-435c-87fc-781a08efb847|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2021-02-19|2021-01-27|38|15
e|DS|171a6d85-ba2e-45da-b31b-01651b26e890|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-08-13|2020-08-11|21|19
e|DS|a8338164-1bb5-4474-9432-4d5a81ab30d8|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2020-12-27|2020-12-15|27|15
e|DS|6d64077e-1f18-4bd6-ba86-53d90121f7a9|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-08-01|2020-07-04|55|27
e|DS|91d08486-3db7-4c71-a63f-fd060f4ae1a4|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-03-02|2021-01-24|77|40
e|DS|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2020-08-13|2020-08-06|9|2
e|DS|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-01-24|2021-01-12|25|13
e|DS|87998e13-813a-464d-935c-d5513cd0db5e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-10-10|2020-09-28|50|38
e|DS|7812e96e-ea53-4eb0-8160-d4118c567c9d|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-03-09|2021-02-05|51|19
e|DS|f9c6c448-0e3d-421f-a63f-be4aeb965256|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-11-02|2020-11-01|4|3
e|DS|e8da815a-b53c-46f4-a546-e8553152719f|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2021-01-19|2020-12-26|33|9
e|DS|701d794b-07b4-4394-a2a4-d31a9f5b743a|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2021-02-10|2021-02-06|22|18
e|DS|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2021-03-22|2021-03-09|97|84
e|DS|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2020-10-27|2020-10-01|88|62
e|DS|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2021-03-23|2021-01-09|90|17
e|DS|bb2487c3-cc05-48f8-9031-0e433c07e3d6|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2020-11-25|2020-11-21|6|2
e|DS|2661da18-b539-49d8-ac80-9da03c127d21|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-09-27|2020-08-04|73|19
e|DS|f1835786-c567-4235-9bd1-f7ffcec12741|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-09-12|2020-07-30|47|3
e|DS|019eb415-1da3-40fa-b4ba-b1f381ec3cac|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-09-06|2020-07-16|68|16
e|DS|2506c6e2-018f-4300-b3b5-44ff8d6e13df|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-07-31|2020-07-18|18|5
e|DS|65c439f8-9658-4ac5-9eae-0837182a90fd|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-08-30|2020-06-14|97|20
e|DS|5b73ad4c-bb28-47d1-a2f6-8508444059a5|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-06-09|2020-06-05|7|3
e|DS|16dcaefa-701c-4863-b010-8ac640aeb55a|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-07-04|2020-06-10|27|3
e|DS|4c19e870-9195-41d8-9c8a-8a54bb428732|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-10-15|2020-09-25|83|63
e|DS|7682184f-0801-4315-9c5f-116f7321a2b0|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2021-02-25|2021-02-05|75|55
e|DS|c40f9cb3-b597-4614-8ba5-d40849030ff9|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-12-25|2020-12-13|23|11
e|DS|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-11-21|2020-10-25|83|56
e|DS|c9308aa7-f38f-4b54-a919-d3f893b18cd1|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2021-01-30|2021-01-23|94|87
e|DS|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-11-01|2020-10-14|81|63
e|DS|3da865e8-9680-4112-b6d3-1f5763cfdaae|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2021-02-13|2021-01-30|34|20
e|DS|60afc3a3-56b7-4988-9006-e12f3bc1097c|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-09-09|2020-08-30|34|24
e|DS|440119fb-ad46-4348-b236-8e2979c7bf2e|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-03-06|2021-02-13|90|69
e|DS|af45a9de-c8aa-4602-8e3b-d16998740ebd|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2020-08-15|2020-06-19|71|14
e|DS|23306866-3fcb-418d-861b-de3bd779260d|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2020-09-10|2020-08-22|57|38
e|DS|144d2eb9-d79a-4a61-91f5-6a807832d8ca|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2020-10-15|2020-09-09|82|46
e|DS|92855d33-eee6-449f-a9e6-c06a1532571f|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2020-12-29|2020-11-30|40|11
e|DS|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-03-05|2021-01-22|45|3
e|DS|40cb9bc3-abec-4158-bdee-becdeceba727|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-12-31|2020-12-19|83|71
e|DS|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-25|2020-10-17|18|10
e|DS|616b284a-3fed-4009-bafe-7da10acd537e|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-09-14|2020-09-02|21|9
e|DS|d39b53da-187f-4da6-9614-2bd301e9ad05|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-10-30|2020-09-24|38|2
e|DS|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-01-02|2020-11-28|39|4
e|DS|e51cf168-af89-44d9-9e56-14785071f6b0|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-01-27|2020-11-19|71|2
e|DS|8416f8c6-d0e4-43fc-9a66-6a916e853e87|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2020-06-23|2020-06-17|20|14
e|DS|a110e924-90a1-4e84-b47a-410f800fa201|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-11-19|2020-11-17|31|29
e|DS|40681cb8-5d49-4e1d-b893-f5fad62a0885|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-08-02|2020-07-31|4|2
e|DS|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-02-03|2020-12-31|58|24
e|DS|96e65c5c-723c-42d9-8e88-0bcb600e9f88|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-15|2020-09-13|15|13
e|DS|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-08-16|2020-07-20|45|18
e|DS|f81742a2-5250-43d7-a6e2-8fcb1625a114|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2020-06-16|2020-06-15|27|26
e|DS|c6bad1d0-3514-4f98-b229-d093a94dfbc4|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-08-25|2020-06-18|72|4
e|DS|84d68bcc-dc7a-4366-9630-40ce8885351d|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-08-18|2020-07-20|73|44
e|DS|517f3930-5202-4e0a-b3e1-85ed4bd7e117|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2021-03-28|2021-01-29|89|31
e|DS|edd73650-27bb-474f-bab7-d2c3d57b2dc4|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2021-02-10|2021-02-07|61|58
e|DS|98737dfa-0058-4420-a515-38526f01f90d|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-11-02|2020-10-31|64|62
e|DS|e713c631-cdd8-428f-a3a6-0195f6fb80b4|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-10-25|2020-10-17|32|24
e|DS|a3964bed-1273-4bce-bbb4-b8d768b30aa3|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-11-15|2020-11-09|66|60
e|DS|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2021-03-16|2021-01-04|95|24
e|DS|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-06-09|2020-06-08|10|9
e|DS|597ff319-c16e-4aae-a7d9-ed2bc25684dc|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-06-19|2020-06-10|32|23
e|DS|7d845e3e-8bd1-4647-a3e8-352a52b585cb|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2021-01-25|2021-01-05|88|68
e|DS|7e9f4283-f90b-4f74-939c-b42648e8373c|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2021-02-23|2020-12-07|80|2
e|DS|20a637e6-83d2-4a86-9ecc-8ddb0523997f|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-12-04|2020-12-01|44|41
e|DS|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2020-07-07|2020-06-24|62|49
e|DS|595aa95c-4378-47c1-96e9-5512d08fb653|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-10-12|2020-09-28|60|46
e|DS|b528dc24-e791-41b1-95b3-fc0be18da47f|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2021-02-01|2021-01-24|46|38
e|DS|7a43c892-0e7f-4f33-9130-e175e475531f|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-07-18|2020-06-18|72|42
e|DS|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2021-01-30|2021-01-21|61|52
e|DS|bde9096e-9ab9-45fe-8e96-1ec9762824a0|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-10-15|2020-09-26|59|40
e|DS|ea7907aa-811e-48ec-9fc6-ab8affde8913|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-09-23|2020-07-26|97|38
e|DS|3aa9935c-943d-406a-bb6e-fc067fa8a487|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-09-21|2020-09-04|35|18
e|DS|0cac2007-ca12-45ba-9b1c-70f753232f05|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-11-24|2020-11-23|3|2
e|DS|2339e91a-b93e-426f-9b60-3d3b6969268d|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-10-03|2020-09-21|98|86
e|DS|0d09e35b-e864-4492-a341-21c71d92b551|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2021-01-16|2021-01-03|88|75
e|DS|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-07-24|2020-06-27|59|32
e|DS|0a5b1036-cd00-4221-b218-ee2664e5a43e|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2021-03-27|2020-12-31|94|8
e|DS|a4f74465-7abc-4cc2-a0be-25d1c802af8c|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-11-04|2020-09-23|45|3
e|DS|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-11-22|2020-11-08|20|6
e|DS|e7262592-01e8-4cb3-b967-ec1037505e81|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-09-21|2020-09-04|19|2
e|DS|bf150829-1b25-418a-9bc6-61716984387c|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2020-09-08|2020-08-10|95|66
e|DS|5c1cc260-97a0-493c-bc11-57f31ffd7455|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-11-03|2020-09-02|68|6
e|DS|cca2835b-ca8d-4db6-89b4-9f2855968a8a|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-09-28|2020-08-05|81|27
e|DS|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-10-02|2020-10-01|5|4
e|DS|74cd0a4f-f9fe-4df9-93b8-7832512d0828|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-06-03|2020-05-20|29|15
e|DS|09238251-feaf-45a9-b295-dfed9a75fbb2|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2020-08-05|2020-07-30|50|44
e|DS|3e896568-85dc-4a14-ba41-eb3575940a9d|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-02-20|2021-02-13|35|28
e|DS|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-01-19|2020-10-26|99|14
e|DS|725c5a91-72b0-4b2c-a51a-d1006303373e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2020-12-28|2020-11-21|45|8
e|DS|5bf5b31d-a59d-46b7-8f8f-97919d449565|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-01-06|2021-01-03|15|12
e|DS|7fc35880-1672-4e64-ba3b-aa3f1e42764b|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-07-05|2020-05-27|50|11
e|DS|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-12-01|2020-10-16|58|12
e|DS|f8878ffd-67af-414c-b346-596dbec640cf|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-01-04|2020-12-29|10|4
e|DS|d8212248-cd8c-4404-8ad8-2c89c05bee9e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-05-31|2020-05-14|30|13
e|DS|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-07-22|2020-07-12|30|20
e|DS|b832144e-88c4-4ad6-b173-abac7802a36c|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-03-30|2021-01-24|85|20
e|DS|6acacd87-c487-401c-8888-76ccf97b640d|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2020-06-20|2020-06-10|36|26
e|DS|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-07-29|2020-07-23|23|17
e|DS|73988e01-56c0-4b31-84e2-c23ce0bac5ac|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-02-10|2021-01-24|48|31
e|DS|0670f6a3-18c9-4027-91c1-56f5555589a8|1|[?]|DEATH|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-06-19|2020-06-12|47|40
e|DS|59179734-8784-4a88-aa6b-51b6082ffc1b|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-08-25|2020-08-21|24|20
e|DS|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2020-09-11|2020-09-08|30|27
e|DS|01c642f8-48ef-4375-aa2b-d0940b74e580|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-09-19|2020-09-13|10|4
e|DS|c0e7028c-6f5c-410a-afde-e56af2177983|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-07-26|2020-07-16|30|20
e|DS|eba928ed-9434-4e75-b49d-169298f966e1|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2020-08-20|2020-08-06|18|4
e|DS|4772aa80-2097-4867-a549-b6f9b140f141|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-09-24|2020-08-31|84|60
e|DS|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-08-18|2020-08-13|82|77
e|DS|4d8dd0d0-407d-4374-8345-c11f30603273|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-01-05|2020-12-28|14|6
e|DS|6996077b-556a-47b9-bbff-20c1b4df35ea|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-08-04|2020-07-09|67|41
e|DS|d79d31c5-d51a-46a7-b22c-20d6d483f46e|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-12-15|2020-12-05|63|53
e|DS|738d539e-a810-4207-8904-fc6a5d055424|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-01-28|2021-01-27|30|29
e|DS|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-09-09|2020-08-04|39|3
e|DS|20841d37-0444-4d1d-b934-1e805cdacdaf|1|[?]|DEATH|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2021-02-16|2020-12-07|96|25
e|DS|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2020-11-16|2020-11-07|25|16
e|DS|d74682f1-824e-449d-bdf1-db517d8fdf2e|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2020-08-25|2020-08-18|27|20
e|DS|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2021-03-06|2020-12-22|99|25
e|DS|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-03|2020-08-08|73|47
e|DS|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-12-21|2020-11-24|44|17
e|DS|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-12-15|2020-11-08|59|22
e|DS|b5644705-65e9-4d9b-9f5c-f8f62d26e257|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-12-28|2020-12-16|14|2
e|DS|ec82f59b-197a-4ccc-b5e5-d91627a86a27|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2020-05-24|2020-05-09|18|3
e|DS|527fd604-110f-47b1-bd8b-b1de2f5b0d29|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-12-31|2020-12-12|42|23
e|DS|1e1de453-920a-4132-b2f7-6335ee81ec83|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-12-03|2020-11-30|52|49
e|DS|e553ad8e-96f4-4cb0-a005-51e9b64513b7|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-07-30|2020-07-22|41|33
e|DS|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-12-09|2020-12-08|3|2
e|DS|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-08-22|2020-07-21|84|52
e|DS|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-01-09|2020-11-17|82|29
e|DS|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2021-03-18|2021-03-07|94|83
e|DS|ad04ec90-9fd5-49f2-ae23-264273eb0a24|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-11-05|2020-10-28|29|21
e|DS|a1d203ef-7ee1-4373-988a-370532bae2b1|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-03-18|2021-02-22|59|35
e|DS|4389d158-cb51-4779-b19a-f38dbef0806a|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-07-01|2020-06-25|19|13
e|DS|3a973b7a-3583-4383-b59e-3dab51b511bd|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2021-03-30|2021-02-13|80|35
e|DS|d283591c-2085-459e-94f2-d3eb6b81aea7|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-10-01|2020-09-28|13|10
e|DS|da31f695-9f6a-46b2-8002-5c1c21b55cf3|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-12-14|2020-11-07|84|47
e|DS|4cd63e56-3d93-403a-8011-3b4fcf26e445|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2021-03-17|2021-01-08|90|22
e|DS|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-08-15|2020-06-03|94|21
e|DS|f31bab3b-3624-44a5-a62f-f8cf9055eec4|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-08-31|2020-08-28|32|29
e|DS|0b5675aa-4ec0-4548-9a0b-a13f8de89883|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2020-09-02|2020-08-08|76|51
e|DS|9bdf9856-3b2a-43db-b369-3e13868ef413|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-02-08|2021-01-15|26|2
e|DS|5cc53922-60c0-4bce-8d4a-bc59e9203d63|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2021-01-31|2021-01-05|44|18
e|DS|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2021-01-14|2020-12-21|26|2
e|DS|066281d3-27b8-439f-8340-f59115f646ef|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-01-08|2020-11-15|89|35
e|DS|d23cc47e-da96-4042-a69f-60097beaef0e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2021-03-21|2021-03-12|69|60
e|DS|b896c679-87d0-4e29-ad27-3944cf09b3ec|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2021-01-09|2020-12-27|17|4
e|DS|6d0ec221-6eb6-4fed-806e-2bc700968333|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-09-19|2020-08-11|64|25
e|DS|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2020-12-29|2020-12-14|97|82
e|DS|15e5e7ca-b832-450c-a20c-b21585086328|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2021-02-23|2021-01-14|59|19
e|DS|b46ff3a2-f257-4803-8064-e29bd1114bfc|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-12-28|2020-11-24|86|52
e|DS|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-12-23|2020-12-22|27|26
e|DS|a5c667d1-d2ac-49f7-ad44-bf9a44762025|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-11-28|2020-09-28|63|2
e|DS|944a2627-13f1-4ecf-9545-8819a1327138|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-04-06|2021-03-09|89|61
e|DS|7902955a-6336-45e5-a15d-7c368a28ac4f|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-06-21|2020-06-10|30|19
e|DS|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2021-03-13|2020-12-12|93|2
e|DS|6071d81f-2f38-414f-90ca-4ad80c971054|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-11-04|2020-09-27|68|30
e|DS|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-12-01|2020-11-22|74|65
e|DS|a046d48d-b1fa-4d46-902e-3984aed00ec7|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-07-28|2020-07-26|6|4
e|DS|8b60e1b0-2cd9-419d-b345-9006af042932|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-03-14|2021-02-25|98|81
e|DS|712029bc-471a-4e3d-9123-e38b3c38bc6c|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-04-14|2021-01-19|90|5
e|DS|92c0183d-5704-45ad-9aec-e24bc5777b80|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2021-03-05|2021-02-14|54|35
e|DS|52ce3b1f-9500-4323-861d-73c8b96f59de|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-10-25|2020-10-19|9|3
e|DS|3655d198-2e7e-419e-8337-d7eea7d795ca|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2021-02-12|2020-12-13|91|30
e|DS|d47da6bf-8abf-4b62-8bb8-797155981158|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2020-09-12|2020-09-02|12|2
e|DS|25e81c81-8c23-4c9e-be79-35247384dd1f|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2020-08-28|2020-08-14|30|16
e|DS|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-09-19|2020-08-03|64|17
e|DS|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2021-01-10|2020-12-07|69|35
e|DS|5ba70148-c29b-47af-9280-10d1a942380a|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2021-01-27|2021-01-01|70|44
e|DS|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-07-14|2020-06-22|58|36
e|DS|2d8f8b1e-7914-400b-afc5-8dc23a626d76|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-06-11|2020-06-11|2|2
e|DS|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-11-01|2020-09-25|83|46
e|DS|a73142e4-e34b-4144-b95f-7a5562574c1b|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-09-01|2020-08-03|34|5
e|DS|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-06-09|2020-05-29|16|5
e|DS|0f682806-b63c-4c3f-9fda-1e59befbd3a3|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-06-20|2020-06-10|32|22
e|DS|1d8aba56-f62e-4116-b447-899dedd3d4df|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-12-21|2020-11-12|93|54
e|DS|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-29|2020-09-12|86|39
e|DS|383d3f30-14b7-48c3-b1a8-0f481ef37a50|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-07-14|2020-07-11|47|44
e|DS|b4f81b74-fee9-4544-9404-206d931ed8e5|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-10-28|2020-10-14|20|6
e|DS|9e69b457-20db-45e5-a535-0cd8ac102fea|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-08-09|2020-06-10|73|13
e|DS|14211798-ddf6-47c8-bd9d-056d95bad8ff|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-04|2020-09-21|18|5
e|DS|63f3194e-9b88-491a-9a68-19109ed86e2b|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-07-17|2020-07-03|47|33
e|DS|b6208258-d7c2-4dde-addf-4677946ab165|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-12-09|2020-09-30|90|20
e|DS|a669a7b9-2034-4bca-aa80-0371c5fb46d3|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2021-03-16|2021-01-22|59|6
e|DS|e148c13d-ee41-4503-a7e5-397dd6155f04|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-09-06|2020-07-20|60|12
e|DS|815de94a-f259-41ee-8951-8df150184a25|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-09-24|2020-09-23|89|88
e|DS|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2020-07-19|2020-06-19|74|44
e|DS|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-01-18|2021-01-17|3|2
e|DS|a616ef00-05d6-459a-8474-06ab3eb493b1|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-11-03|2020-09-29|49|14
e|DS|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2020-10-27|2020-08-30|78|20
e|DS|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2021-01-12|2020-11-30|93|50
e|DS|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-09-12|2020-08-01|80|38
e|DS|2014bcd0-1430-4096-87f5-650a01dae626|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2020-06-19|2020-06-05|29|15
e|DS|e043f1b3-6b65-45c0-bdae-eb783406c263|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2021-02-07|2021-02-06|98|97
e|DS|45623c39-86de-4b2f-bf2d-998d0e941e92|1|[?]|DEATH|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2020-07-16|2020-07-15|4|3
e|DS|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2020-11-12|2020-10-22|35|14
e|DS|e5a105f7-38ac-4f19-aace-4149ed9b1100|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-11-08|2020-09-24|76|31
e|DS|c568ab93-8e7f-4e4e-9685-f0c13f293606|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2021-04-05|2021-01-10|91|6
e|DS|bccd8af0-2ecf-4091-92e4-681597b57ca4|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-11-22|2020-11-06|63|47
e|DS|bf069a02-03a6-4013-b16d-d7c954a6cc3d|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-29|2020-10-13|94|78
e|DS|c40fc52b-2668-4fab-b051-5b258da72f2c|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-11-28|2020-11-14|58|44
e|DS|d7c792d8-fc98-41ab-8a9e-59de1e186a06|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-10-17|2020-10-13|91|87
e|DS|f7773659-f207-4b29-8389-3aa766a6337a|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-11-15|2020-11-02|37|24
e|DS|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-02-24|2021-01-04|58|7
e|DS|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-03-31|2021-03-07|74|50
e|DS|700049a2-ef66-466b-b1d8-f0800bcfde43|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2020-09-08|2020-08-28|83|72
e|DS|00d906a6-2d14-4199-aff9-524388c5117f|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2020-11-19|2020-11-18|5|4
e|DS|2fcc5910-bce0-4510-b17e-3925850d6d32|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2021-01-07|2021-01-02|32|27
e|DS|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2020-09-17|2020-09-12|27|22
e|DS|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-10-15|2020-09-08|91|54
e|DS|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-12-07|2020-11-23|50|36
e|DS|ff163542-abec-4260-b257-f15a11e580ee|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-10-16|2020-10-11|71|66
e|DS|bb73f732-a52f-4013-9ae6-60ff23b9c224|1|[?]|DEATH|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-10-20|2020-08-02|86|7
e|DS|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2020-07-18|2020-07-14|7|3
e|DS|8e056558-ffd2-4c43-bbfa-40914b38af34|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2021-01-31|2021-01-29|12|10
e|DS|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-06-15|2020-05-22|27|3
e|DS|624c1353-347a-417d-9aab-7f1e7077ba7f|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-08-20|2020-08-20|2|2
e|DS|ef1cddb8-f4ce-45c4-8671-32fe95f00993|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-10-06|2020-08-20|75|28
e|DS|da6294b5-de91-4bf7-b160-55d22fefcb07|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-07-09|2020-06-26|21|8
e|DS|c01c16d4-7a37-421d-9191-1874eba6a1e3|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-12-16|2020-10-20|78|21
e|DS|6036407d-5ac8-400d-91f7-afd63f3cab88|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-08-25|2020-07-26|74|44
e|DS|69cf0c4b-13f6-4955-8046-72a333059d6e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2021-01-06|2020-12-17|31|11
e|DS|19829028-595c-4811-90e3-0ca696a04ba3|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-10-06|2020-09-15|93|72
e|DS|562a8182-8e9b-4a68-9b95-bc52df58ed46|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2020-10-24|2020-09-04|59|9
e|DS|b29e6912-42f4-471b-ad90-1ec446f89ac0|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2021-01-12|2021-01-11|3|2
e|DS|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-08-03|2020-07-17|65|48
e|DS|396295ba-9f4c-4689-88c2-f80cb28b567a|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2020-12-24|2020-12-23|3|2
e|DS|56072c44-67c3-4c93-8db7-2d1570b2bbbc|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-22|2020-08-23|37|7
e|DS|55b23180-01f2-498e-a0af-cb9cd7d81750|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2020-06-25|2020-06-23|4|2
e|DS|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2020-11-27|2020-11-10|28|11
e|DS|940e4aef-5648-46b3-9c3e-7c40f7930030|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-11-14|2020-11-13|9|8
e|DS|e4bece1e-6672-4b55-824f-56aa923e60f9|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-08-07|2020-07-04|56|22
e|DS|12e607da-f53c-4078-9742-23a111db6f54|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-11-07|2020-09-29|45|6
e|DS|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2021-03-09|2021-03-08|52|51
e|DS|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-08-10|2020-07-14|35|8
e|DS|3260122d-3bf4-45ff-a026-2379158721d0|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-08-06|2020-08-02|73|69
e|DS|05eb4e29-887e-4cdb-8854-49939a8a13d1|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-11-24|2020-11-04|29|9
e|DS|c8390c70-766d-4252-9356-39591651bcdf|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-08-17|2020-08-07|16|6
e|DS|a40bf877-c070-40b3-89df-d566b942246e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-06-17|2020-06-16|11|10
e|DS|e9633621-3d08-4b47-b394-5bd3fa47c07f|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2021-03-17|2021-02-03|70|28
e|DS|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|1|[?]|DEATH|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-08-16|2020-06-29|79|31
e|DS|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2020-08-17|2020-07-18|42|12
e|DS|63f43990-e56e-440c-a445-76e7d114cf26|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-10-21|2020-10-13|29|21
e|DS|380c89f4-2650-4a54-92f5-5e1278b9a91e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-12-28|2020-10-17|77|5
e|DS|84c1f5f4-6415-49d8-b854-22e7529d65b6|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-12-16|2020-12-08|21|13
e|DS|77c26a0c-0c84-44d7-8351-a50f3236e59a|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2020-07-31|2020-07-10|88|67
e|DS|a201c78a-e826-4f42-a997-7c6a019e2c91|1|[?]|DEATH|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-08-13|2020-08-04|20|11
e|DS|c41880bd-1e29-4961-b74d-bb0d979ab00f|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-09-14|2020-09-05|13|4
e|DS|7de60015-fa9d-4a39-bd19-51c718a624e6|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-11-28|2020-11-05|45|22
e|DS|34d03f58-155a-4908-bba3-aa979be84610|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-07-15|2020-07-09|26|20
e|DS|3818424f-cbc9-4e79-94b8-7edbc706bdbc|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-28|2020-10-25|76|73
e|DS|4191788e-b2dc-4885-87d8-da9feb6deea5|1|[?]|DEATH|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-11-14|2020-11-11|74|71
e|DS|8572a9c4-eb87-4745-81b9-8316bc8de69e|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2021-02-18|2021-02-12|66|60
e|DS|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-01-25|2020-12-20|70|34
e|DS|3eceae61-a4a0-49fd-964b-9f142e0da067|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-28|2020-09-15|41|28
e|DS|fe7ad71c-601d-4909-b56a-401c9a10f00c|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-05-22|2020-05-20|11|9
e|DS|cc52d895-5819-46c0-b8e6-b948f1cd2408|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2020-07-18|2020-06-30|22|4
e|DS|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2021-01-28|2021-01-25|9|6
e|DS|1409edea-a372-4938-889b-df6ee93b8543|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-10-11|2020-09-21|55|35
e|DS|3dc16ad2-d49d-4fad-9823-d0197fb57a42|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-11-02|2020-09-28|69|34
e|DS|7c244128-0508-422f-88ba-ecce68cec054|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-09-25|2020-08-23|61|28
e|DS|247814c7-9fb3-43f2-9e0a-db70b27b3d95|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2021-01-07|2020-12-25|32|19
e|DS|e870fe2f-b08c-41d9-a672-07da09fe2b99|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2020-10-20|2020-09-29|79|58
e|DS|32979638-fb88-4cbb-a110-a4d2016e9bc5|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2020-08-22|2020-08-18|48|44
e|DS|39b8db88-810b-4402-9ca3-c2bab1939c1c|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2021-01-17|2020-11-22|73|17
e|DS|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-07-26|2020-07-23|9|6
e|DS|bca1f50d-04e6-46f5-afb3-e48aaea1069d|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-11-10|2020-10-30|17|6
e|DS|6bddadef-13fb-4fab-b281-aa33aa97aa8f|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2020-06-07|2020-06-03|24|20
e|DS|6edb7414-d8f4-44da-8483-504b93a7e705|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2020-08-13|2020-06-14|77|17
e|DS|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2020-08-04|2020-05-29|90|23
e|DS|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-07-07|2020-06-10|60|33
e|DS|47d55e87-e559-424d-a6ad-d533a0d77f39|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-04-11|2021-02-23|99|52
e|DS|f89c08df-2e24-4c97-a451-1980cecebf14|1|[?]|DEATH|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-03-11|2021-01-14|93|37
e|DS|dbb225ed-e322-4946-a60a-0fafd7e22953|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2021-01-22|2021-01-16|8|2
e|DS|95e61698-43f7-4cc5-aafa-06dac7870743|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2021-01-20|2021-01-03|36|19
e|DS|151308c7-03aa-4a0b-b13f-9838edb218ef|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-10-17|2020-09-07|44|4
e|DS|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-07-07|2020-06-16|32|11
e|DS|23605586-1b30-4f05-bb15-417dd3a79994|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-11-02|2020-10-25|12|4
e|DS|57d15ac0-06a6-40e0-9201-4d947651c9b0|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-09-18|2020-09-09|31|22
e|DS|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-11|2020-10-07|70|66
e|DS|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-09-02|2020-08-26|12|5
e|DS|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-03-19|2021-01-07|95|24
e|DS|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-09-24|2020-09-14|94|84
e|DS|81f62132-123e-4888-abbe-8e289599e965|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-12-31|2020-12-08|37|14
e|DS|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2020-06-16|2020-05-08|41|2
e|DS|49282406-97ec-4108-adf9-e01c18ce59c6|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-06-14|2020-05-20|38|13
e|DS|310936c8-7d24-4eea-9892-1cd8bb675421|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-09-08|2020-07-22|74|26
e|DS|034e303b-5675-4188-bcea-fc2e53b155d6|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-06-09|2020-05-25|18|3
e|DS|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|1|[?]|DEATH|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-08-12|2020-08-02|46|36
e|DS|c912affb-cbc2-4919-81b4-ecaa03908261|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-08-25|2020-07-23|54|21
e|DS|5af817f0-5dfb-4046-ac7c-4bae16a90036|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-07-21|2020-07-20|25|24
e|DS|dcefd656-a59a-4b71-9260-efcbcecd2132|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-07-29|2020-05-29|65|4
e|DS|641c8067-941a-4f1a-a7b1-4eea0242f1d7|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-01-15|2020-12-15|34|3
e|DS|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2020-10-05|2020-09-16|21|2
e|DS|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-11-28|2020-11-20|38|30
e|DS|46304edd-0b05-4819-8fcb-35cf9c02764d|1|[?]|DEATH|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2021-02-02|2021-01-29|71|67
e|DS|3fd6dab2-b35f-4cc5-88dd-b507583d9539|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-05-19|2020-05-18|3|2
e|DS|daa3b89e-637a-43de-86c1-d0db93f00430|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-12-26|2020-10-08|86|7
e|DS|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2020-07-05|2020-06-29|11|5
e|DS|c22014f2-2d7b-4897-8ad5-e46785e51837|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-15|2020-08-12|43|9
e|DS|987102b2-fe2f-4d72-b8dc-14a71bf034b5|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-10-21|2020-10-09|20|8
e|DS|24ce0c77-1921-4b87-91da-3627e2afd399|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2021-02-04|2021-01-30|16|11
e|DS|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-09-13|2020-08-18|34|8
e|DS|f4b83a72-7cde-4e02-8883-05e789c617a8|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-03-10|2021-01-23|85|39
e|DS|c4087538-422a-4bcf-af25-ed4aab36ed4b|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-03-01|2021-02-02|61|34
e|DS|947aefaf-20c7-47fc-ac56-140f9b6f38f3|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2021-01-31|2020-12-24|96|58
e|DS|3a0c00eb-5614-4053-844d-6bdb71efb1cd|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2020-08-30|2020-08-21|29|20
e|DS|dc3ce247-24dd-4255-85a8-ec7a58d30c86|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2020-12-22|2020-12-04|82|64
e|DS|61c19f94-bdfc-456d-ba7a-c9097ca1c645|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2020-08-05|2020-07-14|42|20
e|DS|1e577f2d-2c45-477d-b74f-af24b81d6d20|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-10-03|2020-09-19|20|6
e|DS|f845101e-c057-4f84-94b3-6043afb42ac7|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-01-12|2020-10-23|87|6
e|DS|4ddb2076-6837-4028-81bc-3e8057475977|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-01-24|2021-01-08|38|22
e|DS|c165c69c-2ab2-495c-a190-e32d1204bc4e|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2021-01-27|2021-01-21|36|30
e|DS|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2021-02-01|2021-01-22|44|34
e|DS|024a9f6d-4ff1-4673-8617-3790f831fce7|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-07-21|2020-06-14|48|11
e|DS|40936fc6-251d-4a17-ae9d-3bd1150f8d20|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2021-02-13|2020-12-23|97|45
e|DS|17b9fa7a-f15d-423a-9671-99cd0cbbd362|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2021-01-05|2020-12-11|65|40
e|DS|95c4465b-162a-433d-83c9-6d67dd729c9e|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-12-30|2020-12-15|79|64
e|DS|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-08-27|2020-07-10|71|23
e|DS|beb6b1ab-1264-456a-bf2b-81e28493301d|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2020-08-05|2020-06-29|66|29
e|DS|4292c06d-044e-4dff-aea0-830178a6e220|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-01-17|2021-01-06|56|45
e|DS|050c12d2-cf9f-402b-9332-d6a9771ed115|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-21|2020-08-18|44|10
e|DS|2f1073e4-607f-423f-a5de-f531b828e2d3|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-11-06|2020-10-28|32|23
e|DS|df466903-3212-4e73-bff0-a183447c7408|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-11-30|2020-11-29|39|38
e|DS|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2020-07-07|2020-07-06|4|3
e|DS|c37df2f6-be8a-4709-b97d-061ab9754e0d|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-07-27|2020-07-25|5|3
e|DS|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-05-11|2020-05-08|8|5
e|DS|cec9e0ce-4d09-470c-9c26-df661d316a69|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-12-30|2020-12-28|4|2
e|DS|b98b4e19-51ac-40cc-80d5-cb6d8000c112|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-02-27|2021-01-25|51|18
e|DS|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-09-06|2020-08-03|71|37
e|DS|4bc30b18-c8d8-41a3-91d5-33b8b064087b|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-07-05|2020-07-04|3|2
e|DS|7ff27a70-0472-4cc1-b057-6b161ab29568|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2021-02-01|2020-12-29|84|50
e|DS|40529b01-9a80-4ada-a8df-96eec0e65043|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-07-15|2020-06-25|38|18
e|DS|f3e22efc-0948-4c6e-9173-8e284d342d33|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2021-02-13|2021-01-31|79|66
e|DS|919eb5b4-a3df-41c6-86f7-c78501bb4335|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-09-24|2020-09-23|3|2
e|DS|f918d6e0-6fc2-4303-b323-521c5d531773|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2020-09-14|2020-09-06|55|47
e|DS|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-01-06|2020-12-12|53|28
e|DS|4b1e011f-a16d-4ff6-902d-451d5d13ee97|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-07-24|2020-06-22|43|11
e|DS|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2020-10-11|2020-07-25|94|16
e|DS|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-12-28|2020-12-08|41|21
e|DS|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2021-02-28|2021-02-04|91|67
e|DS|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-21|2020-06-29|87|3
e|DS|7f1e0661-ebbd-4abd-9031-cb6b424977e2|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-01-05|2021-01-03|33|31
e|DS|324a2c67-4802-4806-aff2-04fb9c7394d4|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2020-06-03|2020-05-24|17|7
e|DS|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2021-01-15|2021-01-09|37|31
e|DS|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-10-19|2020-09-05|66|22
e|DS|911dc297-91cb-42b1-8a26-18f6c83c32a6|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-02-18|2021-01-28|89|68
e|DS|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-02-13|2021-01-17|90|63
e|DS|9bfcd733-2233-4e54-a6cd-641a59fc8a01|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-09-09|2020-08-22|35|17
e|DS|7eb97152-173c-4923-8604-5dad3140cc25|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-22|2020-09-23|57|28
e|DS|0b2104d0-e1e3-4516-8c4b-de5d42f82784|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-10-15|2020-09-24|78|57
e|DS|96f68979-6869-403b-a8bd-78c8f965f98a|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-07-31|2020-07-07|76|52
e|DS|e0f67610-b86a-4f5a-88eb-905b1e0aa609|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-10-16|2020-10-09|10|3
e|DS|d62dc655-8865-4592-af0b-744524d9a24c|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-11-22|2020-10-21|64|32
e|DS|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2021-01-18|2021-01-14|20|16
e|DS|8005bd56-3bd6-477a-a466-b9a3bd189770|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2021-02-05|2021-01-08|54|26
e|DS|078ea33d-4114-4320-9116-740b8385a94e|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-07-22|2020-07-18|6|2
e|DS|1ca91975-9a42-4f4d-9c55-53f7561d82fa|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-06-21|2020-06-01|28|8
e|DS|c5f292ad-1729-402b-820f-83ecd29ba00d|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2020-08-12|2020-06-13|75|15
e|DS|a746aefb-16c8-43db-a0c4-8e9a4efdb244|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-08-24|2020-08-10|68|54
e|DS|7f95b9c0-3b77-4c60-8890-ecc955f97122|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-11-06|2020-10-05|52|20
e|DS|2be43c56-83f3-4148-9cb1-97c6d191d20e|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-10-30|2020-10-15|37|22
e|DS|e27e0325-5fbe-46c0-8264-982d83124203|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-09-11|2020-08-16|76|50
e|DS|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2021-01-24|2021-01-17|46|39
e|DS|29e08650-9eae-461f-981e-f2a20d8d4492|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2020-12-21|2020-12-16|44|39
e|DS|2b944a62-10bc-475e-a90d-da3f07a2c4df|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-27|2020-09-26|36|35
e|DS|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-12-02|2020-10-07|94|38
e|DS|8aa77db3-b078-4073-a7f3-9b9a7fb14570|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-12-28|2020-11-25|56|23
e|DS|1fce031b-680b-414f-9b74-d6383e10091d|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-08-01|2020-07-01|72|41
e|DS|dcc67696-e91a-4cef-81dd-f2d2711363ae|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2021-02-17|2021-01-31|61|44
e|DS|91e83d7a-186a-4fed-8750-af796d77d356|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2020-06-01|2020-05-31|9|8
e|DS|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-06-14|2020-05-11|42|8
e|DS|0145dfac-a107-4368-b358-bcd136e1ecb3|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2021-02-25|2021-01-02|58|4
e|DS|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-03-24|2021-02-23|95|66
e|DS|d4d79f6a-ba90-4503-934b-8a86286d83d3|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-12-18|2020-11-11|41|4
e|DS|a329c350-49e2-415d-ba3c-e1ee929aec86|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-11-08|2020-09-19|95|45
e|DS|ff0e3543-c1f3-47f8-987f-7b00a4a33704|1|[?]|DEATH|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-09-24|2020-09-23|3|2
e|DS|128153ce-7bee-4f8d-bb60-fb1776370b6d|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-03-07|2021-01-28|65|27
e|DS|22ee2f20-4a66-458f-a153-9d7e871e1db2|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-07-12|2020-06-29|35|22
e|DS|b7caaa04-bcc7-4350-ad98-85670a19778f|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-20|2020-07-18|86|22
e|DS|2b58d5fd-3ec8-415b-bb53-a252049f228a|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2021-03-03|2021-01-20|86|44
e|DS|60b23345-43f6-42eb-9225-5a674456c9b9|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2021-04-05|2021-01-11|90|6
e|DS|7979239e-2a6b-48e3-9d11-41c97b33d229|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-01-21|2021-01-14|16|9
e|DS|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-09-01|2020-08-18|36|22
e|DS|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2021-02-12|2021-02-07|48|43
e|DS|da35fc01-4258-4e4d-99d9-4172e84c46e8|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-08-26|2020-08-25|45|44
e|DS|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-23|2020-09-22|60|59
e|DS|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-02-04|2021-01-16|62|43
e|DS|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-07-29|2020-06-13|60|14
e|DS|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-08-08|2020-07-11|86|58
e|DS|136d59c6-9645-447a-a047-68d33dbb708e|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-10-27|2020-10-15|43|31
e|DS|2e393b90-213c-4661-ad55-cabb2008bf14|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-08-10|2020-07-25|55|39
e|DS|f72002d8-262b-49da-84a4-42e6011286f0|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-11-22|2020-10-20|49|16
e|DS|68869dda-531d-4218-b2b0-4f5f46825569|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2021-01-06|2020-11-30|39|2
e|DS|68888445-1819-4f4c-bd0c-a445906476fb|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2021-03-15|2021-03-03|70|58
e|DS|b2ce31a0-513a-449a-aa2c-7c9668fde275|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2020-07-08|2020-07-02|24|18
e|DS|6c1d481b-985a-4be0-97ca-ecd06a81b456|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-12-26|2020-11-26|92|62
e|DS|645a9247-efcb-4641-9514-58d6e28560e0|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2021-01-23|2020-12-30|43|19
e|DS|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-10-05|2020-09-22|30|17
e|DS|05b05951-b1ba-4c51-b50f-9c842532bc4e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-09-16|2020-08-31|60|44
e|DS|ab38e976-8c2b-48ff-bdba-5a056637ecdd|1|[?]|DEATH|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2020-12-06|2020-11-08|54|26
e|DS|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2020-09-16|2020-09-03|26|13
e|DS|51a49847-6405-4842-b549-0e2ab99f61b2|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2021-04-12|2021-04-01|96|85
e|DS|44dcfb9a-c590-4826-a28c-b5e9f83129d5|1|[?]|DEATH|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-08-07|2020-06-02|88|22
e|DS|98166d74-caa7-4693-a817-b2cbae947ff8|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-04-01|2021-02-08|90|38
e|DS|cb07675a-2042-44da-a1f9-8b7783347e88|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2021-02-23|2020-12-15|90|20
e|DS|a8a14aa1-4484-4bbc-86bf-c44257146a26|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-07-21|2020-06-28|30|7
e|DS|dfa4c661-9317-4bec-b307-a31eeadcaba6|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-07-05|2020-06-10|41|16
e|DS|9ed984a9-c153-4729-9dc9-3bb3d9059919|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2020-09-03|2020-08-24|12|2
e|DS|fb234b67-3c81-4d55-bc63-2389a23d67b2|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-02-08|2021-01-22|38|21
e|DS|84d7ff44-cbe2-446f-b667-5bc539de519b|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-07-22|2020-07-20|26|24
e|DS|c96e4485-4aff-4c18-9c65-5f1a800cc6db|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-11-20|2020-10-17|67|33
e|DS|955188f1-b434-40ab-94c8-0c0fb7f23e84|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2021-01-12|2021-01-01|39|28
e|DS|5a384b5e-954c-4af9-bd60-96aadc72ca44|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2020-11-17|2020-10-30|49|31
e|DS|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-07-07|2020-06-29|15|7
e|DS|f9432d72-f7d7-4cdf-a173-2e2029258474|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2021-01-24|2021-01-01|75|52
e|DS|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-12-14|2020-12-11|5|2
e|DS|0fc0650f-ed95-422d-b407-dcee93178780|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2020-11-13|2020-10-09|92|57
e|DS|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2020-07-14|2020-07-04|51|41
e|DS|a6f48290-787a-46ad-bee1-ae263ad3c121|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2021-01-26|2021-01-13|17|4
e|DS|565e5c83-9c67-4718-bd54-af34be936427|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-07-06|2020-06-22|37|23
e|DS|b238304c-15ef-4c6e-a32c-9cd583a233a9|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2021-02-03|2021-01-25|37|28
e|DS|c273f039-bca9-4d55-8620-5c5db32a6c4b|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-12-17|2020-11-22|95|70
e|DS|2cdb5053-2108-4f50-8906-8afabc855a36|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-10-23|2020-09-27|66|40
e|DS|fce7149a-503e-4209-8c62-8044a2ad1c1c|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-09-10|2020-08-25|45|29
e|DS|c8aad550-11a1-4473-8b35-79b7dfb08122|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-06-11|2020-06-01|12|2
e|DS|f1967c6e-c520-4482-be7e-01ada4380d87|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2021-03-24|2021-01-14|88|19
e|DS|2a5a1c03-f54e-47da-8dda-2104c9423e94|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-02-23|2021-02-15|63|55
e|DS|8f98bac3-8010-4902-8ae1-783dc5fea72d|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-07-18|2020-06-24|29|5
e|DS|0fd7cece-4d9d-4d8c-82e0-df0c75613888|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-01-30|2020-12-29|60|28
e|DS|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-07-20|2020-06-09|47|6
e|DS|4be1ea69-9baf-45b4-873b-13a879544d9c|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-02-27|2021-02-10|42|25
e|DS|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-10-27|2020-10-23|8|4
e|DS|16720f71-55b5-478f-b041-00b61ae19ac9|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2021-01-17|2021-01-12|17|12
e|DS|4349f45e-f18b-4606-9a72-fd45e64e17dc|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-01-16|2021-01-11|15|10
e|DS|32e36ec1-6895-42ff-bf33-52977e72b338|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2020-08-28|2020-08-28|2|2
e|DS|e546f2d8-baea-4a6e-93cb-c7ec7292b423|1|[?]|DEATH|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2021-01-22|2021-01-07|99|84
e|DS|0329de16-fc7a-4941-900c-b390dac637aa|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-09-27|2020-09-22|10|5
e|DS|89d364c9-1338-472b-af0b-19280e45508b|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-12-11|2020-12-08|67|64
e|DS|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2020-08-20|2020-05-20|95|3
e|DS|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-10-28|2020-10-09|26|7
e|DS|0c103005-efae-48ed-91e3-35d38fa1d359|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-06-16|2020-06-06|29|19
e|DS|c9808184-3432-448c-a5e5-50176715effa|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2021-03-07|2021-01-16|78|28
e|DS|c3d7d293-975f-44de-bd35-0168eec40ac9|1|[?]|DEATH|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2021-03-31|2021-01-23|96|29
e|DS|2db1f07d-a7db-4cc3-8943-536e24378f08|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2020-08-13|2020-07-02|72|30
e|DS|c343ba98-87d7-40bc-b0e8-b866e42d3a21|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2021-02-02|2020-12-18|59|13
e|DS|d2b31ba9-9718-43ce-82ca-3276c28ac42a|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2021-03-02|2021-01-19|98|56
e|DS|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-10-03|2020-09-02|82|51
e|DS|0a42f96a-49c3-492f-a272-bf9989e53e9d|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-02-25|2021-01-24|40|8
e|DS|a78e7287-581c-4bf2-b3ca-ad2476c010cd|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-01-07|2021-01-05|9|7
e|DS|d3651e5f-bc38-4c96-afbf-5a65873ff306|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2020-09-01|2020-07-24|45|6
e|DS|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2020-07-30|2020-07-04|59|33
e|DS|f50537d2-e098-4dae-8f91-16f2357d709c|1|[?]|DEATH|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2021-03-01|2020-12-09|94|12
e|DS|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-08-24|2020-07-21|46|12
e|DS|489870ed-9da5-4df6-a5ef-17821c449c84|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2020-10-07|2020-09-11|79|53
e|DS|90fe992f-5a11-4829-b3b0-1c8314f53012|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2020-10-05|2020-10-02|22|19
e|DS|74be8de0-3307-4cc3-9044-05068b60f7e0|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-10-18|2020-10-17|8|7
e|DS|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-08-18|2020-06-14|78|13
e|DS|8825b806-fa76-49d7-b281-d36fc42fee1e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2020-10-14|2020-10-11|56|53
e|DS|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-08-15|2020-07-16|98|68
e|DS|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2021-04-01|2021-01-17|87|13
e|DS|b36220d8-c129-48bf-8c41-542a954b819a|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2020-05-22|2020-05-18|8|4
e|DS|92d3477b-7460-4ce8-b237-38ca4c55fc91|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-08-22|2020-08-15|18|11
e|DS|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-12-14|2020-12-10|8|4
e|DS|db13afe0-14f6-445b-869a-b0d9fe87e5b9|1|[?]|DEATH|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-09-17|2020-08-25|36|13
e|DS|3f75a463-1348-4c7f-8b29-7472d29628c8|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-08-24|2020-07-31|53|29
e|DS|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2021-01-27|2021-01-24|7|4
e|DS|4b00b9ef-ddc3-4669-8a73-f69c73743bce|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-10-07|2020-09-06|86|55
e|DS|a125efdf-aec8-47a1-b492-cdaf8b619a78|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-10-10|2020-10-05|20|15
e|DS|9171362e-0166-46f2-ab2d-2748d8c291d5|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-03-18|2021-03-06|75|63
e|DS|9b150e38-dc85-4a28-aad3-43f7620be460|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-10-12|2020-08-20|92|39
e|DS|2a595fc0-7621-4ec9-bd77-74444886052e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-11-15|2020-11-08|31|24
e|DS|0bab89c8-cf57-4d19-9b95-884a2e9da523|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2021-03-17|2021-01-11|97|32
e|DS|84edaa9d-ce48-4866-ab43-af91bee126ae|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-07-28|2020-07-01|88|61
e|DS|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-08-22|2020-08-11|29|18
e|DS|9734ec2a-d06b-43e1-82a5-37764af17890|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-12-22|2020-10-07|94|18
e|DS|9a0ce525-7f10-4651-885a-f64bd9c8925e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2021-01-21|2020-12-10|64|22
e|DS|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2020-09-16|2020-08-20|73|46
e|DS|4ba88073-0003-461a-a950-4504ef7680e7|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-09|2020-09-19|47|27
e|DS|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-09-25|2020-09-13|34|22
e|DS|f552fa78-d78f-44c5-9590-30a737e6652d|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-12-27|2020-10-30|93|35
e|DS|38d83f86-d8ce-461a-a288-95aebe498d22|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2020-11-11|2020-09-25|88|41
e|DS|b31e8820-cc17-4ce5-af30-358dbeb12ba2|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-11-03|2020-09-29|92|57
e|DS|cf39d5bd-7682-4546-8495-5bcf48600a69|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-03-27|2021-02-23|76|44
e|DS|84c17e7b-8d56-4726-96a5-9ca41fb9d894|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-02-08|2021-01-09|86|56
e|DS|6e557fd7-efaf-4c86-806d-9bd66c7de7da|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-02-07|2021-01-21|21|4
e|DS|2b25e1f9-929c-4bdc-8758-79f33b832026|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-10-17|2020-10-11|8|2
e|DS|d02c7553-17f5-44ec-8c24-469234d080e8|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2021-04-11|2021-02-07|85|22
e|DS|e819939e-548d-4e05-83e3-7976790de7e1|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2020-09-02|2020-08-31|5|3
e|DS|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-08-10|2020-08-10|2|2
e|DS|ea5229ad-6469-4147-be40-546d27c04c4c|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-06-10|2020-06-07|11|8
e|DS|0a566742-0f71-4603-85f0-875e2c3395e7|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2021-04-02|2021-03-20|94|81
e|DS|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2020-05-26|2020-05-20|22|16
e|DS|48103500-0f3d-4108-9167-6afee1098773|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-05-24|2020-05-23|19|18
e|DS|9855fc59-f162-48ba-8c51-e8c6c54b72f3|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2020-09-25|2020-09-03|72|50
e|DS|ceab42b0-3a7e-4aad-b599-5da311398148|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2020-08-13|2020-08-09|63|59
e|DS|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2020-08-17|2020-08-14|49|46
e|DS|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-08-02|2020-07-17|33|17
e|DS|36a54b72-6368-460e-ab4c-952923e0fd14|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2020-07-20|2020-05-23|76|18
e|DS|84e56692-9a33-472a-9ddc-545d3342da34|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-02-05|2021-01-09|58|31
e|DS|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-08-14|2020-07-23|85|63
e|DS|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2020-09-02|2020-06-19|94|19
e|DS|ae0e05c1-3953-4406-bfae-299295c1fa4c|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2021-03-01|2021-01-24|58|22
e|DS|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-04-06|2021-03-28|90|81
e|DS|ab09e76d-8bbf-4126-a60d-08d6b5292836|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2021-01-15|2021-01-05|31|21
e|DS|8b7e3909-4115-4736-b07a-e0b6c382aa7e|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-07-28|2020-07-26|27|25
e|DS|187b2279-526f-4978-89d4-d2da56cc2257|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-08-31|2020-08-10|81|60
e|DS|53506a04-dedb-495b-8e35-0576cdf1b323|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2021-01-22|2020-12-20|86|53
e|DS|defa600c-4205-476e-a40c-690cb16769b3|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2021-04-20|2021-03-28|96|73
e|DS|e5092583-4259-40ba-a6a2-eeef6607263b|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-11-16|2020-11-14|71|69
e|DS|461196d1-1213-4e5f-9bac-71f097b6cfdb|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-11-05|2020-11-05|2|2
e|DS|4c82922a-55d0-45b9-a7bb-4edac32b0f68|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-12-21|2020-12-05|22|6
e|DS|57971bdc-14df-4d9e-a59a-2665703c12ab|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2020-07-26|2020-06-22|67|33
e|DS|dacea2da-9101-41e9-97aa-1cb8445b1320|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-25|2020-10-19|26|20
e|DS|cbf5d05e-e934-4946-b991-5fef63a01888|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2021-01-27|2020-12-15|92|49
e|DS|be18633c-0ff9-4775-9737-dc8a9524fd2c|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-22|2020-10-10|14|2
e|DS|f7eba9b8-94fb-46b8-842a-0322eb68a355|1|[?]|DEATH|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-06-03|2020-05-30|32|28
e|DS|903199e2-56e1-41e4-8904-d33cc6846ee3|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2021-02-17|2021-02-12|40|35
e|DS|32567f8d-e746-44e1-a269-d95ba3bb0b11|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-11-17|2020-10-29|25|6
e|DS|ecdc54eb-c02f-4112-8e85-8a3352470b3b|1|[?]|DEATH|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2020-12-07|2020-11-15|36|14
e|DS|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-07-10|2020-07-03|11|4
e|DS|5d7241ec-120d-486d-ab39-b9e14ab4ce90|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-10-20|2020-10-01|90|71
e|DS|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-06-05|2020-05-30|14|8
e|DS|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-08-29|2020-08-22|66|59
e|DS|a69c6182-9c35-4365-b732-b238e0584ba7|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-08|2020-08-18|42|21
e|DS|1b9896cf-160e-4a56-8737-9759cd83e784|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-01-21|2020-12-19|51|18
e|DS|ea87b553-e331-40cf-bd86-d2bd22694476|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2020-09-21|2020-09-19|57|55
e|DS|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-10-23|2020-08-14|95|25
e|DS|051dc064-be6f-43eb-aa51-7ed8634d6e23|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-07-15|2020-07-12|17|14
e|DS|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-06-18|2020-06-04|25|11
e|DS|7a17fe21-b640-4bc5-bf19-b1bceb393dab|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-11-19|2020-09-28|88|36
e|DS|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2021-03-12|2021-02-27|61|48
e|DS|f1d0daec-aa97-4838-9c53-e16dae3e17b2|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-09-13|2020-07-08|92|25
e|DS|835594ab-e93c-402b-8129-6af659be5ae1|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|WASHOUT|2020-11-15|2020-10-28|24|6
e|DS|c3c85786-d24b-4620-9ee0-c13b1cc4f951|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2020-11-07|2020-10-14|41|17
e|DS|5354e3c4-4106-4e4c-85c3-2dbbd001688c|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2020-11-17|2020-11-08|12|3
e|DS|f10e9188-ef7b-46f9-a80a-0669436eb4dd|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-06-20|2020-06-18|6|4
e|DS|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-08-17|2020-08-05|14|2
e|DS|000b5b99-a92d-4c84-9edc-ee08930d8a2e|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-12-11|2020-10-21|67|16
e|DS|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-08-25|2020-08-10|95|80
e|DS|11b2b359-d4a1-411d-a676-075b26e1453c|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2020-11-16|2020-11-04|67|55
e|DS|293f673d-af6a-473e-8bce-118bb85bbd9e|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-11-28|2020-11-23|50|45
e|DS|0f60ab31-ee13-4846-93d2-6bcac139006f|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-05|2020-08-04|75|43
e|DS|d49f37ce-2d6e-4ebb-91af-7ed32322f824|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-10-30|2020-10-13|70|53
e|DS|76dd2fe2-bc9e-48e4-870c-af7ece70009a|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-07-24|2020-07-23|28|27
e|DS|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2021-02-06|2020-11-18|84|4
e|DS|78778706-6b5b-4ad8-90af-f56d602863ae|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-07-12|2020-06-25|70|53
e|DS|a6954aa1-4860-412a-b988-7f708aca2ab2|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-10|2020-09-13|33|6
e|DS|0a970eb4-f958-42ad-ad8b-60bb427c9cba|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2020-06-16|2020-05-10|43|6
e|DS|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2021-01-23|2021-01-22|7|6
e|DS|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-11-20|2020-09-10|98|27
e|DS|9b268a13-dc40-4eb6-8729-c131ac302dd3|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-06-21|2020-05-07|47|2
e|DS|fa11534a-92f9-4887-828b-25b7637b8f57|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-12-14|2020-12-10|11|7
e|DS|f305f7a3-8c8b-4eca-afb2-4a376f811170|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2020-10-27|2020-10-01|33|7
e|DS|6e4ed6b3-e419-464c-a40e-f100a6894baa|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-07-24|2020-06-30|57|33
e|DS|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-09-07|2020-08-17|40|19
e|DS|5d25ac6d-428d-41eb-9549-c23df035a54e|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-06-20|2020-06-03|48|31
e|DS|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-12-05|2020-11-12|46|23
e|DS|173aea61-964d-4f4a-8d48-56a1a58de6d8|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2020-10-30|2020-10-16|27|13
e|DS|45d1adb8-9b3b-4f06-87cb-740205448680|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-07-21|2020-07-10|14|3
e|DS|7403ad67-7ed5-4716-a874-c360429845bc|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-08-27|2020-07-17|99|58
e|DS|8be919ce-34da-4e49-ac7a-3679c7af632d|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-03-27|2021-02-04|83|32
e|DS|9c44967b-914e-43d5-be1e-6829804e04ab|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2021-04-15|2021-01-29|91|15
e|DS|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2020-10-21|2020-09-20|92|61
e|DS|cad8c553-739f-4046-a898-d939eb286dba|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-07-18|2020-05-17|72|10
e|DS|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-09-09|2020-09-05|8|4
e|DS|81e934f8-7bcc-48d2-8d15-5270e51f2870|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2021-04-11|2021-01-22|87|8
e|DS|5713cabe-4d79-4f77-8ddc-daad1242a837|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-10-17|2020-10-02|48|33
e|DS|414d20c7-8dc8-49ad-8ae9-f113b9610109|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-12|2020-07-25|74|25
e|DS|21e16094-23bd-4d20-b5f8-10d45858160e|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|FOLLOW-UP|2020-09-16|2020-09-09|9|2
e|DS|2346613e-6734-476a-a414-511606c2d753|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-11-25|2020-10-03|74|21
e|DS|6a8bda83-1b5a-481e-af4f-77fe74bc37be|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-12-31|2020-11-29|45|13
e|DS|748ef401-3def-4674-8d5e-4a198709d672|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-05-31|2020-05-31|2|2
e|DS|03c399c1-77b9-4879-a6e8-42ba58ca68d4|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-09-27|2020-08-21|84|47
e|DS|b8afdaf1-5c4d-408f-b8ba-381461f15bde|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-11-30|2020-11-22|27|19
e|DS|8115d6e8-0908-4491-a82a-08f43ccf1f0d|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-02-16|2021-01-03|90|46
e|DS|fbd7ecb2-905f-40a9-babc-ebaf310cc372|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-08-08|2020-08-03|49|44
e|DS|1a0e1a66-82dd-4945-9c9f-179fba9d781e|1|[?]|DEATH|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2021-02-26|2021-01-08|89|40
e|DS|b3ab1879-3dc7-41fa-be53-f4484af21fbd|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-12-24|2020-12-12|45|33
e|DS|bc71ddfa-c71c-447b-9684-005e4c112172|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-08-09|2020-07-07|39|6
e|DS|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2021-02-03|2021-01-01|66|33
e|DS|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-11-05|2020-09-09|70|13
e|DS|b1b3e113-8c73-4446-8095-3341f8912bd7|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2021-02-22|2021-02-21|36|35
e|DS|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-01-05|2020-11-22|54|10
e|DS|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-09-18|2020-08-28|53|32
e|DS|3b83c7a0-e22b-45b1-b065-71971f014039|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-10-21|2020-09-20|60|29
e|DS|92c849ce-12b8-4c38-baab-f91c44a007b9|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2020-11-04|2020-11-04|2|2
e|DS|f2101018-c983-435e-a453-148f182388f7|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-09-06|2020-09-04|15|13
e|DS|613284eb-edbe-446b-b4fe-f96f1510e626|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-01-24|2021-01-17|88|81
e|DS|65e8391b-0c34-4687-a0ab-cb291a4cdf36|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-09-30|2020-08-28|87|54
e|DS|2350438a-0bc8-4da5-b6c9-99a6c012b454|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2020-09-19|2020-09-16|39|36
e|DS|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2021-02-04|2020-11-18|90|12
e|DS|416fe99b-1258-4e72-b1df-48b989f8f8ed|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2020-11-19|2020-10-14|93|57
e|DS|16a9e070-3e5d-444c-9ac1-6a1abfac0370|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-07-31|2020-06-05|76|20
e|DS|1497a00d-55b1-4e02-a957-cf15e3d15512|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|FOLLOW-UP|2021-03-07|2021-02-05|51|21
e|DS|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-08-02|2020-07-28|22|17
e|DS|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2021-03-04|2020-12-05|95|6
e|DS|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-11-15|2020-11-10|20|15
e|DS|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-08-19|2020-07-17|94|61
e|DS|2216086b-197e-4780-8e10-28123eb090c5|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-03-01|2021-01-16|89|45
e|DS|7280f69c-a0f4-48b5-b714-1e272193168c|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-18|2020-09-15|40|37
e|DS|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2020-09-26|2020-09-05|66|45
e|DS|25c6812b-9200-4dc4-a954-6879183a2c54|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-12-21|2020-12-16|7|2
e|DS|10dca475-f364-42f3-9192-faf762832adf|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-11-29|2020-09-21|75|6
e|DS|caf54095-56c3-428f-8342-ce45c6c9a287|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-12-13|2020-12-12|3|2
e|DS|f833ca56-d426-420b-a6d3-fedeabc02734|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2020-09-05|2020-08-14|87|65
e|DS|03c8e2c7-b70d-4d46-8064-c99370eab232|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-01-14|2020-12-19|56|30
e|DS|944617c7-c5e6-4e06-b114-499c3020dbbd|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-10-31|2020-10-14|19|2
e|DS|e4878c66-1e2b-49bb-838e-85139d160dd4|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-12-24|2020-12-13|74|63
e|DS|6873e227-baef-4d6e-8600-0bb61d60fe49|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-08-22|2020-07-11|87|45
e|DS|bad01879-9b97-4d9c-9eec-58871168bd57|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-12-08|2020-11-30|64|56
e|DS|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-11-30|2020-11-02|35|7
e|DS|0df77775-6e65-4f77-9f8f-7faaa1471141|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-10-28|2020-10-20|75|67
e|DS|adc5359a-f1d5-428b-97d8-fce67cfeeaea|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-10-15|2020-09-22|64|41
e|DS|cd68296c-95d4-489e-8b64-b2404f16316c|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-01-20|2020-12-12|41|2
e|DS|fe137506-d1ce-4b08-a043-9366d86c421e|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2020-07-28|2020-07-11|35|18
e|DS|b112c524-42c8-4e9e-8699-209e739972a7|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2021-01-08|2020-12-26|15|2
e|DS|e6e32df8-8b66-49a5-a626-fd385297dd6f|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-10-04|2020-09-11|42|19
e|DS|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-12-07|2020-10-01|90|23
e|DS|5002de57-45df-4525-a6b7-b6cc33c22229|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2021-02-24|2021-02-02|53|31
e|DS|298f2081-bb11-4856-9e88-4be3b9b2250d|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-12-08|2020-10-28|74|33
e|DS|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2021-01-31|2020-12-25|43|6
e|DS|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-05-25|2020-05-07|23|5
e|DS|18c21176-db5e-4650-a1af-beb2042c31d8|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-08-22|2020-08-22|2|2
e|DS|7808abd1-7d6f-4090-aa08-916a804c95f5|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-09-14|2020-08-01|96|52
e|DS|57553b78-e761-4577-aae2-5c693a2dc303|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2021-02-23|2021-01-12|63|21
e|DS|40883550-4627-4f92-974a-7eeb5bde74c5|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|SCREENING|2021-01-02|2020-10-07|91|4
e|DS|4199b549-d021-4bfd-97e6-95630d407183|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-01-29|2020-12-22|68|30
e|DS|6366647f-62fa-48dc-9d77-1677fce62fc7|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2020-09-29|2020-07-20|87|16
e|DS|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-07-22|2020-07-02|80|60
e|DS|637d7d5f-78d3-47fb-b6dc-d877d92b9001|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|SCREENING|2020-08-24|2020-05-28|92|4
e|DS|696cd04a-cde7-4481-b5e2-fad1877ec284|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-09-29|2020-09-24|39|34
e|DS|ce4699cb-66f1-4c13-8428-84064255b765|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-12-22|2020-12-06|30|14
e|DS|015b391b-23c7-478d-b9d1-226d3cb9edcf|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2021-02-19|2021-01-23|92|65
e|DS|b510a277-c5ee-4a32-b111-b2dbc72c8a27|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2020-09-01|2020-08-26|96|90
e|DS|9e9acf6b-d29a-4c11-96d6-b580c721f462|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-09-21|2020-08-26|42|16
e|DS|da69b157-7dab-49c5-b8fb-bd312a21fcf0|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-07-10|2020-07-10|2|2
e|DS|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-06-21|2020-06-17|33|29
e|DS|77c97d1e-e223-4485-b2de-59daa4e5b01f|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-09-03|2020-08-06|86|58
e|DS|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-11-22|2020-10-11|49|7
e|DS|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2020-12-08|2020-11-13|47|22
e|DS|9eb6e591-d266-4e05-85b6-230e8a02d494|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|FOLLOW-UP|2020-06-27|2020-06-24|9|6
e|DS|6a6e040d-6a09-4004-9fab-f4f82ba00eae|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|FOLLOW-UP|2020-07-30|2020-06-26|40|6
e|DS|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2020-10-24|2020-09-21|78|45
e|DS|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-03-17|2021-03-04|67|54
e|DS|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|FOLLOW-UP|2020-06-27|2020-06-19|56|48
e|DS|ba99022a-d398-4c60-828c-876f119459e1|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|FOLLOW-UP|2021-01-26|2020-12-21|66|30
e|DS|d713869e-061c-4e95-8a50-da2e1ec47b3c|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|WASHOUT|2020-06-18|2020-06-02|22|6
e|DS|fcebb64c-e0e6-4f29-9c52-15fa91f60018|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|SCREENING|2020-09-17|2020-08-30|78|60
e|DS|e443f82e-43a8-4710-bff4-fd2b2f4d512f|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-01-26|2020-12-29|35|7
e|DS|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|TREATMENT|2020-07-21|2020-07-16|39|34
e|DS|8a2147b1-2deb-410e-a298-d028a5efc555|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2020-11-12|2020-10-30|23|10
e|DS|033db3bf-17fb-4872-afdb-1eea3dac6d85|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-09-11|2020-07-12|78|17
e|DS|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2020-09-04|2020-07-19|87|40
e|DS|8dd493b7-a892-4cab-8f69-701471c51d99|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2021-03-05|2021-02-08|62|37
e|DS|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-12-14|2020-12-13|47|46
e|DS|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2020-11-22|2020-10-17|89|53
e|DS|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2021-01-04|2020-12-04|55|24
e|DS|b49ef90c-a17e-4554-9fa6-af72b4d56a06|1|[?]|[?]|PROTOCOL MILESTONE|STUDY PARTICIPATION|TREATMENT|2021-03-08|2021-01-30|72|35
e|DS|df041193-ee4e-4835-8db9-5be9b832ded0|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|TREATMENT|2021-02-21|2021-01-04|98|50
e|DS|e41a4505-a5aa-4cac-895b-04fe85737ca9|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|TREATMENT|2021-03-06|2021-01-18|62|15
e|DS|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|WASHOUT|2021-01-25|2021-01-10|20|5
e|DS|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|WASHOUT|2021-02-24|2021-01-02|84|31
e|DS|5abbbb78-2eeb-4d21-85ac-f5d18294c603|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|WASHOUT|2021-02-14|2021-01-28|30|13
e|DS|109fe46d-ac1f-47fe-8ecb-6049a577d38c|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-06-10|2020-05-23|31|13
e|DS|cdb18d0a-5fca-4437-9b6e-0e46b0930521|1|[?]|[?]|OTHER EVENT|STUDY TREATMENT|SCREENING|2020-11-11|2020-10-22|79|59
e|DS|e515b916-5d28-4236-8835-2ff43b498ab3|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|SCREENING|2020-06-02|2020-06-01|20|19
e|DS|158af2a8-d447-45e5-8c58-3b950f1bd889|1|[?]|[?]|DISPOSITION EVENT|STUDY PARTICIPATION|TREATMENT|2020-06-30|2020-06-19|41|30
e|DS|e9a930d5-ca57-4069-8251-c164273df082|1|[?]|[?]|PROTOCOL MILESTONE|STUDY TREATMENT|WASHOUT|2020-05-24|2020-05-13|13|2
e|DS|e654e37e-1c95-4f25-83b1-9233186626c6|1|[?]|[?]|DISPOSITION EVENT|STUDY TREATMENT|TREATMENT|2020-10-08|2020-10-05|75|72
e|DS|808ee0ac-e668-4e8e-aa0a-889476cbe631|1|[?]|[?]|OTHER EVENT|STUDY PARTICIPATION|SCREENING|2020-09-11|2020-09-07|94|90
